Chapter 35
Other Trace Elements
All elements that have not been assigned separate chap-
ters in this volume fit into the category of elements that
have become known as the ultratrace elements. Ultratrace
elements are those with estimated dietary requirements
usually <1 ug/g and often <50 ng/g of diet for labora-
tory animals. 1 At least 18 elements have been suggested
to be ultratrace elements: aluminum, arsenic, boron,
bromine, cadmium, chromium, fluorine, germanium,
iodine, lead, lithium, molybdenum, nickel, rubidium,
selenium, silicon, tin, and vanadium. The quality of the
experimental evidence supporting the suggestion of nu-
tritional essentiality varies widely among these elements.
The evidence for the essentiality of three elements, io-
dine, molybdenum, and selenium, is quite substantial and
noncontroversial; specific biochemical functions have
been defined for these elements. Iodine and selenium are
discussed in Chapters 36 and 31, respectively; molyb-
denum will be discussed here. Specific biochemical func-
tions have not been identified for the other 15 elements.
Thus, their essentiality is based on circumstantial evi-
dence; that is, a dietary deprivation consistently results
in a suboptimal biological function that is preventable
or reversible by an intake of physiological amounts of
the element in question. The circumstantial evidence for
essentiality is substantial for arsenic, boron, chromium,
nickel, silicon, and vanadium; thus, except for chromium,
which is discussed in Chapter 34, they will be discussed
in detail here. The evidence for essentiality of the other
elements is generally limited to a few gross observations
in one or two species by one or two research groups.
Because it was judged premature to discuss these ele-
ments in detail here, these elements will be only briefly
mentioned in table form at the end of this chapter. How-
ever, fluoride, which has a well-known beneficial phar-
macologic property (anticariogenic), is discussed in
Chapter 32.
Arsenic
History. Although arsenic has been considered syn-
onymous with poison for centuries, its bad reputation
did not prevent it from becoming an important pharma-
ceutical agent. By 1937, the pharmacologic actions of
Forrest H. Nielsen
8000 arsenicals had been recorded. Arsenicals were
considered at various times to be specific remedies for
the treatment of anorexia and other nutritional distur-
bances, syphilis, neuralgia, rheumatism, asthma, chorea,
malaria, tuberculosis, diabetes, various skin diseases, and
numerous hematologic abnormalities.' The use of arseni-
cals for these disorders has either fallen into disrepute
or been replaced by more effective alternatives.
Reports describing attempts to produce a nutritional
arsenic deficiency first appeared in the 1930s.3.4 The first
substantial evidence for arsenic essentiality was published
in 1975 and 1976. 5 Arsenic deprivation signs were de-
scribed for rats, pigs, and goats. Subsequently, signs also
were described for chickens and hamsters. Thus, it is only
recently that arsenic has been studied from the biochemi-
cal, nutritional, and physiological, and not only the toxi-
cological or pharmacological, points of view.
Chemistry and method ofanalysis. Both the trivalent
and pentavalent states of arsenic exist in biologic mate-
rial. The most biochemically important organic arsenic
compounds are those that contain methyl groups. The
methylation of inorganic oxyarsenic anions occurs in
organisms ranging from microbial to mammalian. The
methylated end products include arsenocholine, arseno-
betaine, dimethylarsinic acid, methylarsonic acid, trime-
thylarsine oxide, and tetramethylarsonium ion."
Other arsenic compounds of interest are those possi-
bly formed when arsenate replaces phosphate in biologi-
cal molecules. The relatively unstable nature of arsenyl
esters apparently is the reason that only indirect evidence
exists for compounds such as glucose-6-arsenate and
adenosine diphosphate-arsenate. Nonetheless, arsenate
ester might be the form of arsenic that performs an es-
sential function.
A comprehensive review of arsenic chemistry and
biochemistry has been published.' One of the most pre-
cise and sensitive methods for the determination of ar-
senic in biological material involves measuring arsine
generated from dry combusted samples by graphite-fur-
nace atomic absorption spectrometry. 8,9
Absorption, transport, storage, and turnover. Ab-
sorption of inorganic arsenic from the gastrointestinal
tract correlates well with the solubility of the compound
353
354
ingested. io.u In humans and most laboratory animals,
>90% of inorganic arsenate and arsenite fed in a wa-
ter solution is absorbed. However, only 20-30% of
arsenic in arsenic trioxide or lead arsenate, which are
only slightly soluble in water, is absorbed by hamsters,
rats, and rabbits.
The form of organic arsenic also determines how well
it is absorbed. For example, >90% of an oral dose of
arsenobetaine was recovered in the urine of hamsters;
70-80% of an oral dose of arsenocholine was recovered
in the urine of mice, rats, and rabbits; and 45% of an
oral dose of dimethylarsinic acid was recovered in the
urine of hamsters. 12-14 In contrast, >90% of an oral dose
of sodium-p-N-glycolylarsenilate was recovered in the
feces of rats or humans within 3 days of administration;
urinary excretion accounted for only 4-5% of the dose."
Also, most orally administered arsenosugars are not
absorbed from the gastrointestinal tract."
Arsenate and phosphate, despite structural similarities,
do not share a common transport pathway in the duode-
num." The absorption of arsenate can be separated into
two components. First, arsenate becomes sequestered
primarily in or on the mucosal tissue. Eventually, the sites
of sequestration become filled, with concomitant move-
ment of arsenate into the body. The absorption of arsenate
apparently involves a simple movement down a concen-
tration gradient. In rats, some forms of organic arsenic
are absorbed at rates directly proportional to their intes-
tinal concentration over a 100-fold range.'? This find-
ing suggests that organic arsenicals are absorbed mainly
by simple diffusion through lipoid regions of the intes-
tinal boundary.
Once absorbed, inorganic arsenic is transferred to liver,
where it is methylated. Thus, blood contains both inor-
ganic (probably protein bound) and methylated forms of
arsenic. In 56 healthy volunteers consuming a diet high
in organic arsenic, mean blood total arsenic was 7.3 flg/
L and was 73% trimethylated arsenic, 14% dimethylated
arsenic, and 9.6% inorganic arsenic." Before arsenate
is methylated, it is reduced to arsenite via the use of
glutathione. 19,20 Methylation takes place in liver with S-
adenosylmethionine as the methyl donor. 2o ,21 In humans,
the final product, dimethylarsinic acid, results from the
methylation of the monomethylarsenic acid precursor
formed from arsenite." The methylation of arsenic can
be modified by changing the glutathione, methionine, and
choline status of the anirual. 23,24
The fate of absorbed organic arsenic depends on its
form. For example, arsenobetaine passes through the
body into the urine without biotransformation.> Some
orally ingested arsenocholine appears in the urine, and
some is incorporated into body phospholipids similarly
to choline; however, most is biotransformed to arseno-
betaine before being excreted in urine. 13
If the ingestion of arsenic is low, no tissue has sig-
nificant accumulation of arsenic. 26 The highest amounts
PRESENT KNOWLEDGE IN NUTRITION, 7th Edition
of arsenic are usually found in skin, hair, and nails, prob-
ably the result of arsenite binding to SH groups of pro-
teins that are relatively plentiful in these tissues."
The metabolism of arsenic in some animal species is
quite unusual. For example, rats, unlike other mammals,
concentrate arsenic in their erythrocytes." Marmoset
monkeys are unable to methylate arsenite, which is a
major reaction in the elimination of arsenic from the body
for most animals.P-" Studies with rabbits, hamsters, and
chicks seem to give findings on the metabolism of ar-
senic most applicable to humans.
The excretion of ingested arsenic is rapid, principally
in urine. Only minor amounts are removed through sweat,
loss of hair and skin, and bile. lO A reported example of
the proportions of the forms of arsenic in human urine
after an oral dose of inorganic arsenic is 51% dimethyl-
arsinic acid, 21% monomethylarsonic acid, and 27%
inorganic arsenic." The proportions are quite different,
however, with the consumption of organic arsenic. For
example, an analysis of urine from 102 Japanese stu-
dents who consumed luxuriant amounts of organic ar-
senic in seafood revealed 9.4% inorganic arsenic, 3.0%
monomethylarsonic acid, 28.9% dimethylarsinic acid,
and 58.2% trimethylated arsenic compound." Similar
findings were obtained in another study of 56 healthy
volunteers. 18
Physiological (biochemical) function. The evidence
suggesting that arsenic is essential does not clearly de-
fine its biochemical function. Recent findings suggest
that arsenic affects the formation of various metabolites
from methionine (e.g., S-adenosylmethionine, S-adenosyl
homocysteine, cysteine, and taurine) and arginine (e.g.,
putrescine, spermidine, and spermine) or affects labile
methyl-group metabolism.F Arsenic deprivation de-
pressed the concentrations of putrescine, spermidine, and
spermine in liver of rats fed marginal amounts of me-
thionine and depressed the taurine concentration in the
plasma of hamsters.
Perhaps arsenic has a role in some enzymatic reac-
tions.' As an enzyme activator, arsenic as arsenate prob-
ably substitutes for phosphate. As an inhibitor, arsenic
as arsenite apparently affects enzymes by reacting with
sulfhydryl groups.
Arsenic may also regulate gene expression. Arsenite
can induce the cellular production of certain proteins
known as heat-shock or stress proteins.v-" The produc-
tion of these proteins in response to arsenite apparently
is controlled at the transcriptional level and may involve
changes in the methylation of core histones." Recent
findings have shown that arsenic deprivation in the rat,
chick, and hamster affects labile methyl metabolism.P-"
Also, arsenic enhances DNA synthesis in unsensitized
human lymphocytes" and in those stimulated by phy-
tohemagglutinin."
Deficiency signs. Arsenic deprivation has been in-
duced in chickens, hamsters, goats, miniature pigs, and
OTHER TRACE ELEMENTS/Nielsen
rats. 5,32,38 In goats, miniature pigs, and rats, the most
consistent signs of arsenic deprivation were depressed
growth and abnormal reproduction characterized by
impaired fertility and elevated perinatal mortality. Other
notable signs of deprivation in goats were depressed
serum triacylglycerol concentrations and death during
lactation. Myocardial damage was also present in lac-
tating goats. The organelle of myocardium most affected
was the mitochondrion, which was affected at the mem-
brane level;" in advanced stages, the membrane actu-
ally ruptured. Other signs of arsenic deprivation have
been reported. Listing these signs is problematic because
studies with chicks, rats, and hamsters have revealed that
the nature and severity of the signs of arsenic depriva-
tion are affected by several dietary manipulations, in-
cluding variations in the concentrations of zinc, argin-
ine, choline, methionine, taurine, and guanidoacetic acid
(a methyl-depleting agent). The signs of arsenic depri-
vation were changed and generally enhanced by nutri-
tional stressors that affected sulfur amino acid or labile
methyl-group metabolism. However, some recently re-
ported responses to arsenic deprivation that may be sig-
nificant are decreased glutathione S-transferase activity
and increased kidney calcium concentrations in female
rats fed the AIN-76 diet."
In humans, decreased serum arsenic concentrations in
people undergoing hemodialysis treatment were corre-
lated to injuries of the central nervous system, vascular
diseases, and cancer,"
Requirement. Only data from animal studies are avail-
able for estimating the arsenic need of humans. An ar-
senic requirement of <50 ng/g and probably ",,25 ng/g
was suggested for growing chicks and rats fed an ex-
perimental diet containing 20% protein, 9% fat, 60% car-
bohydrate, 11% fiber, minerals, and vitamins.v-" Thus,
the arsenic requirement is apparently between 6.25 and
12.5 f.!g/4.18 MJ (6.25 and 12.5 f.!g/lOOO kcal). From
these data a possible arsenic requirement for humans
eating 8.37 MJ (2000 kcal) would be ""12-25 f.!g/day.42 A 3
A safe upper limit of arsenic intake most likely will be
140-250 f.!g/day.42,43
Food and other sources. The reported arsenic con-
tent of diets from various parts of the world indicates
that the average daily intake of arsenic is generally 12-40
f.!g.~6 However, the dietary arsenic intake by a typical
Japanese person (high-seafood diet) was found to be 195
ug/day (range 16-1039 ug/day)." Fish, grain, and ce-
real products contribute'most of the arsenic to the diet.
Excess (toxicity). Because of mechanisms for the
homeostatic regulation of arsenic, its toxicity through oral
intake is relatively low; it is actually less toxic than
selenium, an ultratrace element with a well-established
nutritional value. Toxic quantities of inorganic arsenic
generally are reported in milligrams. For example, the
estimated fatal acute dose of arsenic trioxide for humans
is 70-180 mg, or ",,0.76-1.95 mg As/kg body weight."
355
The ratio of the toxic to the nutritional dose for rats
apparently is near 1250, Some forms of organic arsenic
are virtually nontoxic; for example, a 10 g/kg body
weight dose of arsenobetaine (common form of arsenic
in food) depressed spontaneous motility and respiration
in male mice, but these signs disappeared within 1 hour,"
Arsenocholine is slightly more toxic than arsenobetaine;
a dose of 5,8 g/kg body weight caused death in some
rats, but a dose of 4.8 g/kg did not."?
Briefly, the signs of subacute and chronic high expo-
sure of arsenic in humans include the development of
dermatoses of various types (hyperpigmentation, hyper-
keratosis, desquamation, and loss of hair); hematopoi-
etic depression; liver damage characterized by jaundice,
portal cirrhosis, and ascites; sensory disturbances; pe-
ripheral neuritis; anorexia; and weight loss.50-52
Results of numerous epidemiologic studies have sug-
gested an association between chronic arsenic overex-
posure and the incidence of some forms of cancer. Al-
though the role of arsenic in carcinogenesis remains
controversial, arsenic does not seem to act as a primary
carcinogen and is either an inactive or extremely weak
mutagen. 53
Summary. Until more is known about the biochemi-
cal and physiological functions of arsenic, it is inappro-
priate to associate specific disorders with deficient ar-
senic nutriture. At present, it is important to recognize
the likelihood that arsenic is essential for humans. Thus,
the belief that any form or amount of arsenic is unnec-
essary, toxic, or carcinogenic is unrealistic, if not po-
tentially harmful.
Boron
History. In the 1870s it was discovered that pharma-
cological amounts of borax and boric acid could be used
to preserve foods. For about the next 50 years, borates
were considered some of the best preservatives for ex-
tending the palatability of foods such as fish, meat, cream,
and butter. In 1904, however, Wiley" reported that hu-
man volunteers consuming >500 mg of boric acid per
day for 50 days displayed disturbed appetite, digestion,
and health. Subsequent to this report, the opinion that
boron posed a risk to health gained momentum; by the
middle 1950s boron was essentially forbidden through-
out the world as a food preservative.
In 1923 Warrington'" showed that boron is an essen-
tial element for plants. About 15 years later, attempts to
demonstrate boron essentiality for higher animals began;
these attempts were unsuccessful.v?" Thus, before 1980,
students of biochemistry and nutrition were taught that
boron was a unique element because it was essential for
plants but not for higher animals. In 1981 it was reported
that boron stimulated growth and partially prevented leg
abnormalities present in cholecalciferol-deficient chicks."
Since then, evidence has been accumulating indicating
356
that boron is an essential nutrient for higher animals
including humans.
Chemistry and methods of analysis. Boron exists in
biological material mainly bound to oxygen. Thus, bo-
ron biochemistry is essentially that of boric acid. Dilute
aqueous boric acid solutions comprise B(OH)3 and
B(OH)4- species at the pH of blood (7.4); because the
pK a of boric acid is 9.2, the abundance of these two
species should be 98.4% and 1.6%, respectively.'"
Boric acid forms ester complexes with hydroxyl groups
of organic compounds; this preferably occurs when the
hydroxyl groups are adjacent and CiS. 63 Among the hy-
droxylated substances of biological interest with which
boron complexes are adenosine-5-phosphate, pyridoxine,
riboflavin, dehydroascorbic acid, and pyridine nucle-
otides. Formation of these complexes may be biologi-
cally important because, in vitro, it results in the com-
petitive inhibition of some enzymes.F These include
oxidoreductases that require cis-hydroxyl-containing
pyridine or flavin nucleotides as cofactors.
The added stabilization of hydrogen bonding between
hydroxyls bound to boron and hydrogen of imidazole
or amido groups allows complexes to be formed between
borate and compounds containing single hydroxyl groups.
Through forming this type of complex, borate and bo-
ronic acid derivatives can form transition analogues that
inhibit the activity of some enzymes." For example,
serine hydro lases are inhibited when a tetrahedral com-
plex is formed between the serine hydroxyl group and
boron, with hydrogen bonding to an imidazole ring of
an adjacent histidine adding stabilization."
Two naturally occurring organoboron compounds have
been identified; they contain boron bound to four oxygen
groups. These compounds are aplasmomycin, a novel
ionophoric macrolide antibiotic isolated from strain ss-20
of Streptomyces griseus, and boromycin, an antibiotic
synthesized by Streptomyces antibioticus.v/" Boromycin
can encapsulate alkali metal cations and increase the per-
meability of the cytoplasmic membrane to potassium ions.
Only recently have methods been developed that can
determine low concentrations of boron in biological
substances with acceptable accuracy. Development of
such methods has been difficult because many boron
compounds volatilize at temperatures far below those
required for most dry or wet ashing procedures, and most
forms of glassware and chemical reagents contain sig-
nificant amounts of boron. Procedures that have been
developed to digest biological substances with minimal
boron loss or contamination include a low-temperature
wet digestion in semiclosed teflon tubes and a teflon
bomb digestion in a microwave oven. 67,68 Inductively
coupled argon plasma spectroscopy is generally used to
determine the boron content of the digestates.P-"
Prompt gamma activation analysis and neutron acti-
vation-mass spectrometry (NA-MS) techniques have
been developed that can accurately measure the usual
PRESENT KNOWLEDGE IN NUTRITION, 7th Edition
or normal concentration of boron in biomaterials." One
major advantage of these techniques is that they do not
require the destruction of the organic matrix containing
boron. For example, with NA-MS, a freeze-dried sample
is irradiated to generate 4He from lOB; the 4He is mea-
sured by mass spectrometry. The sophistication and cost
of the equipment precludes either of these methods from
becoming of general laboratory use.
Absorption, transport, storage, and turnover. Sodium
borate, boric acid, and possibly food boron are rapidly
absorbed and are excreted largely in the urine. Because
there is no usable radioisotope of boron, the study of
its metabolism has been made difficult. However, it is
likely that most ingested boron is converted to B(OH)3'
the normal hydrolysis end product of most boron com-
pounds and the dominant inorganic species at the pH of
the gastrointestinal tract. It is postulated that boron is
absorbed and excreted mainly as undissociated B(OH)r
The mechanism by which boron is transported through
the body has not been defined. Recently, an inductively
coupled plasma-mass spectrometry method using the
ratio of the two stable isotopes, !lB/lOB, was developed
to study boron metabolism. 70 This method was used to
show that boron in broccoli, intrinsically enriched with
lOB, was absorbed as well as extrinsic boron lOB in bo-
ric acid from a test meal by rats. When 20 ug of lOB
isotope were fed to rats, 95% of this isotope was detected
in the urine and 4% in the feces after 3 days. This agrees
with other urinary recovery findings indicating that >90%
of ingested boron is usually absorbed.?':"
Boron is distributed throughout soft tissues and flu-
ids of animals and humans at concentrations mostly
between 0.015 and 0.6 ug/g fresh tissue. 62 ,73- 75 Bone,
fingernails, hair, and teeth usually contain several times
these concentrations.
Evidence showing that boron is homeostatically con-
trolled includes the rapid urinary excretion of absorbed
boron, the lack of accumulation of boron in tissues, and
the relatively narrow range of boron concentrations in
blood of apparently healthy individuals. In a group of
50 blood samples collected from hospitals and clinics
in the United Kingdom, the serum boron concentration
ranged from 0.77 to 4.45 umol/L (8.4 to 48.1 ng/rnl.),
with a median of 2.06 umol/L (22.3 ng/ml.)." In post-
menopausal women, an increase in dietary boron from
0.36 mg/day (probably deficient) to 3.3 mg/day (luxu-
riant) did not increase plasma boron concentrations when
dietary magnesium was 340 mg/day; however, a 2A-fold
increase occurred when dietary magnesium was 109 mg/
day (C.D. Hunt and EH. Nielsen, unpublished data,
1987). Increasing dietary boron from 0.465 (deficient)
to 2.465 (luxuriant) mg/kg diet increased the plasma
boron concentration by only 50% in cholecalciferol-
deficient chicks.i''-" As with other mineral elements,
overcoming homeostatic mechanisms by high boron
intakes will elevate tissue boron concentrations.
OTHER TRACE ELEMENTS/Nielsen
Physiological (biochemical) function. A biochemical
function for boron has not been elucidated, even for
plants for which boron has been known for 70 years to
be essential and for which boron deficiency has a multi-
plicity of effects.Y" Two hypotheses recently advanced
for the biochemical function of boron in higher animals
accommodate a large and varied response to boron dep-
rivation and the known biochemistry of boron. Hunt"
proposed that boron is a metabolic regulator through
complexing with a variety of substrate or reactant com-
pounds in which there are hydroxyl groups in favorable
positions. On the basis of the knowledge that two classes
of enzymes are competitively inhibited in vivo by borate
or its derivatives and his findings showing dietary boron
can alter the in vivo activity of a number of these en-
zymes, Hunt hypothesized that the metabolic regulation
by boron is mainly negative; that is, boron controls a
number of metabolic pathways by competitively inhibit-
ing some key enzyme reactions. Nielsen" hypothesized
that boron has a role in cell membrane function or sta-
bility such that it influences the response to hormones by
modulating transmembrane signaling or transmembrane
movement of regulatory cations or anions. This hypoth-
esis is supported by the recent findings that boron influ-
ences the transport of extracellular calcium and the re-
lease of intracellular calcium in rat platelets activated by
thrombin and that boron influences redox actions in-
volved in cellular membrane transport in plants.":"
Deficiency signs. The listing of the signs of boron
deficiency is difficult because most boron-deficiency
studies have used stressors to enhance the response to
changes in dietary boron. Thus, it has been found that
the response to boron deprivation varies as the diet var-
ies in its content of nutrients such as calcium, phospho-
rus, magnesium, potassium, and cholecalciferol." How-
ever, although the nature and severity of the changes may
vary with dietary composition, many findings indicate
that boron deprivation impairs calcium and energy me-
tabolism. For example, a boron supplement of 3 ug bo-
ron/g alleviated the cholecalciferol-deficiency-induced
distortion of marrow sprouts of chick proximal tibial
epiphyseal plate and elevated the number of osteoblasts
within the marrow sprouts." Boron also substantially
alleviated or corrected cholecalciferol-deficiency-induced
elevations in plasma glucose, changes in energy substrate
use, and depressions in growth."
Brain composition and function are also affected by
dietary boron. Boron deprivation was found to system-
atically influence brain electrical activity assessed by an
electrocorticogram in mature rats; the principal effect was
on the frequency distribution of electrical activity." In
this study, brain copper concentrations were higher in
boron-deprived than in boron-supplemented rats. Further-
more, calcium concentrations in total brain and in brain
cortex, as well as the phosphorus concentration in the
cerebellum, were found to be higher in boron-deprived
357
than in boron-supplemented rats fed a cholecalciferol-
deficient diet.84
Some of the preceding findings may reflect an effect
of dietary boron on macromineral metabolism. The ap-
parent absorption and balance of calcium, magnesium,
and phosphorus were found to be higher in boron-supple-
mented (2.72 ug boronlg diet) than in boron-deprived
(0.158 ug boronlg diet) rats fed a cholecalciferol-defi-
cient diet."
Findings involving boron deprivation of humans have
come mainly from two studies in which men over the
age of 45, postmenopausal women, and postmenopausal
women on estrogen therapy were fed a low-boron diet
(0.25 mg/8.37 MJ [0.25 mg/2000 kcal]) for 63 days and
then fed the same diet supplemented with 3 mg boron/
day for 49 days.8!,85-89 These dietary intakes were near
the low and high values in the range of dietary boron
intakes (0.5-3.1 mg/day) found in a limited number of
surveys.?" In the first experiment the diet was low in
magnesium (115 mg/8.37 MJ) and marginally adequate
in copper (1.6 mg/8.37 MJ) throughout the study.85,86 In
the second experiment the diet provided 300 mg mag-
nesium and only 1.7 mg copper/8.37 MJ for the first 32
days; from day 33 onward, the diet was supplemented
to contain 2.4 mg copper/8.37 MJ.87,88 Thus, the major
differences between the two experiments were the in-
takes of copper and magnesium; in one experiment they
were marginal or inadequate, in the other they were
adequate. Among the effects of boron supplementation
after 63 days of boron depletion in these experiments
were the following: an effect on macromineral and elec-
trolyte metabolism evidenced by increased serum 25-
hydroxycholecalciferol and decreased serum calcitonin
(with low dietary magnesium and copper);86,88 an effect
on energy substrate metabolism suggested by decreased
serum glucose (with low dietary magnesium and cop-
per) and increased serum triglycerides (with adequate
dietary magnesium and copper);":" an effect on nitro-
gen metabolism indicated by decreased blood urea ni-
trogen and serum creatinine and increased urinary hy-
droxyproline excretion;81,85,87,88 an effect on oxidative
metabolism indicated by increased erythrocyte superoxide
dismutase and serum ceruloplasmin.t'F and an effect on
erythropoiesis and hematopoiesis suggested by (all with
adequate dietary magnesium and copper) increased blood
hemoglobin and mean corpuscular hemoglobin content
but decreased hematocrit, platelet number, and erythro-
cyte number," Boron supplementation after depletion also
enhanced the elevation in serum 17B-estradiol and plasma
copper caused by estrogen ingestion, altered electro-
encephalograms such that they suggested improved be-
havioral activation (e.g., less drowsiness) and mental
alertness, and improved psychomotor skills and the cog-
mtrve attenti and memo ry.8889
. . processes 0 f attention '
Requirement. For normal development, chicks appar-
ently require ""lllg boron/g diet." In the human studies
360
composition of the diet. Recent surveys indicate that the
daily intake of molybdenum is 50-350 )lg.122-125 How-
ever, most diets apparently supply ==50-100 ug molyb-
denum/day; thus, many diets do not meet the minimum
level of the suggested safe and adequate intake. The rich-
est food sources of molybdenum include milk and milk
products, dried legumes, organ meats (liver and kidney),
cereals, and baked goods. The poorest sources of mo-
lybdenum include vegetables other than legumes, fruits,
sugars, oils, fats, and fish. 123.126
Excess (toxicity). Large oral doses are necessary to
overcome the homeostatic control of molybdenum. Thus,
molybdenum is a relatively nontoxic element; in non-
ruminants an intake of 100-5000 mg/kg of food or water
is required to produce clinical toxicity symptoms. 102,107
Ruminants are more susceptible to elevated dietary
molybdenum. The mechanisms of molybdenum toxic-
ity are uncertain. Most signs are similar or identical to
those of copper deficiency (i.e., growth depression and
anemia) or indicate abnormal sulfur metabolism. 102,107 In
humans, both occupational and high dietary exposure to
molybdenum have been linked through epidemiologic
methods to elevated uric acid in blood and increased
incidence of gout.
Summary. The essentiality of molybdenum is unques-
tioned. Biochemical functions have been defined for
molybdenum, and signs and symptoms of molybdenum
deficiency have been described. However, except for the
molybdenum-responsive patient with "acquired molyb-
denum deficiency" resulting from long-term use of to-
tal parenteral nutrition, there is no indication that mo-
lybdenum is clinically important. The search for possible
molybdenum-responsive syndromes in humans is still
warranted because situations may be occurring where
molybdenum nutriture is important. For example, low
dietary molybdenum might be detrimental to human
health and well-being through an effect on the detoxifi-
cation of xenobiotic compounds. Molybdenum depriva-
tion depresses the activity of the molybdenum hydroxy-
lases without any apparent overall detrimental effect in
animals; perhaps the same phenomenon occurs in hu-
mans. Low molybdenum hydroxylase activity may have
undesirable consequences when a person or animal is
stressed by high intakes of xenobiotics. The molybde-
num hydroxylases apparently are as important as the
microsomal monooxygenase system in the metabolism
of drugs and foreign compounds. 114
Nickel
History. Although nickel was first suggested to be
nutritionally essential in 1936, strong evidence for es-
sentiality did not appear until 1970. Studies between 1970
and 1975, however, gave inconsistent signs of nickel
deprivation, probably because of suboptimal experimental
PRESENT KNOWLEDGE IN NUTRITION, 7th Edition
conditions. 1,127,128 Since 1975, diets and environments that
allow optimal growth and survival of laboratory animals
have been used in studies of nickel nutrition and me-
tabolism. Thus, most of the significant biochemical,
nutritional, and physiological studies of nickel have
appeared subsequent to 1975.
Chemistry and method of analysis. Monovalent, di-
valent, and trivalent forms of nickel apparently are im-
portant in biochemistry. Like other ions of the first tran-
sition series, Nj2+ can complex, chelate, or bind with
many substances of biological interest. 127 The binding
of divalent nickel by various ligands, including amino
acids (especially histidine and cysteine), proteins (espe-
cially albumin), and a macroglobulin called nickelo-
plasmin, probably is important in the extracellular trans-
port, intracellular binding, and urinary and biliary
excretion of nickel. 129-131 Nj2+, in a tightly bound form,
is required for the activity of urease, an enzyme found
in plants and microorganisms.Pv'" In the microbial en-
zyme, methyl coenzyme M reductase, nickel is present
in a chromophore called factor F43o.133-135 Coenzyme M,
which is involved in methane formation in anaerobic
bacteria, is 2,2'-dithiodiethane sulfonic acid. Factor F430
is a tetrapyrrole similar in structure to vitamin B-12, and
the formation of factor F430 also requires the presence
of Nj2+.
Nj3+ apparently is essential for enzymatic hydrogena-
tion, desulfurization, and carboxylation reactions in
mostly anaerobic microorganisms.Pv'" In some of these
reactions, the redox action of nickel may involve the 1+
oxidation state, especially in that of methyl-coenzyme
M reductase. Nickel also acts as a structural component
in some enzymes.
The determination of nickel in biological material after
appropriate collection and preparation is most precisely
done with great analytical sensitivity through the use of
electrothermal atomic absorption spectrometry.!"
Absorption, transport, storage and turnover. When
nickel in water is ingested after an overnight fast, as much
as 50% but usually closer to 20-25%, of the dose is
absorbed.F'{" This high absorption is depressed by cer-
tain foodstuffs and simple substances, including milk,
coffee, tea, orange juice, ascorbic acid, and ethylene
diamine tetraacetic acid (EDTA).137 Foods such as those
found in a typical Guatemalan meal or in a North Ameri-
can breakfast suppress the absorption of nickel to <1%.137
Thus, nickel is often poorly absorbed 10%) when in-
gested with typical diets. l3 O,l37 Nickel absorption is en-
hanced by iron deficiency, pregnancy, and lactation.P'?"
Pigs were found to absorb> 19% of nickel ingested from
day 21 of pregnancy until parturition.!'"
The mechanisms involved in the transport of nickel
through the gut have not been conclusively established.
Becker et al.142 reported that the transport of nickel across
the mucosal epithelium apparently is an energy-driven
 OTHER TRACE ELEMENTS/Nielsen
process rather than simple diffusion and suggested that
nickel ions use the iron transport system located in the
proximal part of the small intestine. On the other hand,
Foulkes and Mclvlullen-" presented evidence that indi-
cates no existence of a specific nickel carrier mechanism
at the brush-border membrane; thus, nickel absorption
probably depends upon the efficiency of mucosal trap-
ping through charge neutralization on the membrane. This
suggests that nickel crosses the basolateral membrane
through passive leakage or diffusion, perhaps as part of
an amino acid or other low-molecular-weight complex.
The passage as a lipophilic complex is a possibility
because nickel affects the absorption of ferric ions, which
probably traverse biomembranes as lipophilic com-
plexes.v" Oral intakes of lipophilic nickel-pyridinethione
complexes markedly increased the concentrations of
nickel in tissues of mice.r"
The extracellular transport of nickel is probably through
a variety of ligands; however, the principal ligand in blood
apparently is serum albumin. 131 The remaining nickel in
serum is associated with the amino acid L-histidine and
with u z-macroglobulin. I3I ,146
No tissue significantly accumulates orally administered
physiological doses of nickel. Recently reported refer-
, ence values for nickel concentrations in some human
tissues are (mean ug/kg dry weight) lung, 173; thyroid,
\ 141; adrenal, 132; kidney, 62; heart, 54; liver, 50; brain,
44; spleen, 37; and pancreas, 34. 147 The physiological
significance of the relatively high nickel concentrations
in thyroid and adrenal glands is unknown.
Although fecal nickel excretion (mostly unabsorbed
nickel) is 10-100 times as great as urinary excretion, the
small fraction of nickel absorbed from the intestine and
transported to the plasma is rapidly excreted via the
kidney as urinary low-molecular-weight complexes. In
human renal cytosol the low-molecular-weight fraction
contains two nickel-binding components; these are an-
ionic oligosaccharides that bind 70% of the nickel and
an acidic peptide that binds the remaining 30% .148 High-
molecular-weight proteins ranging from 10 to 13 kDa
were also fractionated from renal cytosol and micro-
somes. 149 The role of these proteins in the renal handling
of nickel needs clarification.
Although urine is the major excretory route of absorbed
nickel, significant amounts are lost through sweat and
bile. 130,147,150 The nickel content of sweat is high, which
indicates active nickel s-ecretion by the sweat glands. 150
The loss of nickel through the bile has been estimated
at 2-5 ug/day."?
Physiological (biochemical) function. A defined bio-
chemical function for nickel in higher animals, and thus
humans, has not been described. Recently, however,
functional roles for nickel have been defined for bacte-
ria, fungi, plants, and invertebrates. These roles may
provide clues as to the nature of the biological function
361
of nickel in higher animals; thus, some of them are de-
scribed here.
Since the discovery in 1975 that jackbean urease is a
nickel-containing enzyme, evidence has accumulated
indicating that nickel is a universal component of ure-
ases (urea amidohydrolases, EC 3.5.1.5).132 Nickel has
been found in ureases from bacteria, mycoplasma, fungi,
yeast, algae, higher plants, and invertebrates. Highly
purified urease contains two NF+ ions per 96.6-kDa
subunit. An elegant model proposed for the urease mecha-
nism of action involves the polarization of the urea car-
bonyl by one nickel ion that allows nucleophilic attack
by an activated hydroxyl anion associated with the sec-
ond nickel ion.!"
The hydrogenases are an extremely heterogeneous
group of enzymes. 151 All known hydrogenases contain
iron-sulfur clusters. In addition, some hydrogenases also
contain nickel, or a nickel-selenocysteine bond; these
have been designated as (NiFe) hydrogenases and
(NiFeSe) hydrogenases. Hydrogenases containing nickel
have been identified for over 35 species of bacteria,
including methanogenic, hydrogen-oxidizing, sulfate-re-
ducing, phototrophic, and aerobic Nz-fixing bacteria.
Nickel may be a common constituent of hydrogenases
that function physiologically to oxidize rather than to
evolve H2 The oxidation state of nickel in hydroge-
nase is a point of controversy. However, all parties in
the controversy agree that nickel is redox active and
apparently interacts with the substrate.
In addition to its redox role, nickel also has a regula-
tory role in the production of hydrogenase. Evidence has
been presented that nickel is required for the synthesis
of the hydrogenase mRNA in Bradyrhizobium japo-
nicum.v" For the hydrogenase gene to be expressed, 02
and Hz, when diffused into the cell, affect the redox state
of the nickel bound to a nickel-containing, DNA-bind-
ing protein, which in turn leads to transcriptional regu-
lation of the hydrogenase message.
Carbon monoxide dehydrogenase (carbon monoxide:
[acceptor] oxidoreductase, EC 1.2.99.2; CODH), which
oxidizes CO to COz' is a nickel enzyme that has been
found in acetogenic, methanogenic, phototrophic, and
sulfate-reducing anaerobic bacteria.153.154 In addition to
oxidizing CO to CO 2 , CODH in acetogenic bacteria
catalyzes the reduction of CO 2 to CO and the synthesis
and degradation of acetyl-CoA, and thus can also be
designated as an acetyl-CoA synthase.
Methyl-S-coenzyme-M reductase is the terminal
enzyme in the conversion of CO 2 to methane in
methanogenic bacteria. 133- 135 The enzyme catalyzes
the reductive cleavage of CH 3SCoM to methane and
coenzyme M. The enzyme contains factor F430' which
is thought to be the site of substrate reduction. Fac-
tor F430 has been called a tetrahydrocorphin because .
of its hybrid relationship to corrin and porphynn
362
macrocytic structures; nickel-corphin has been sug-
gested to be a missing link between iron porphyrin
and cobalt corrin systems.
Another nickel porphynoid, tunichlorin, was isolated
from the Caribbean tunicate Trididemnum solidum. 155
Tunichlorin is a blue-green pigment and is identified
as nickel(II) 2-devinyl-2-hydroxymethylpyropheophor-
bide A The function of tunichlorin is unknown but
it is suspected to be involved in a reductive process
similar to that occurring with methyl-S-coenzyme-M
reductase.
Thus, nickel participates in hydrolysis and redox re-
actions, regulates gene expression, and, possibly, sta-
bilizes certain structures. In these roles, nickel forms
ligands with sulfur, nitrogen, and oxygen and exists in
oxidation states of 3+, 2+, 1+, and perhaps 0 and 4+.
Because nickel is so dynamic in lower forms of life,
it most likely has an essential functional role in higher
forms of life, including humans. Supporting this sup-
position is the response of experimental animals when
they are deprived of dietary nickel. Findings indicate
that vitamin B-12 status affects signs of nickel depri-
vation in rats and that vitamin B-12 must be present
for optimal nickel function. 35.I 56. 157 Nickel may have a
function in higher animals that involves a pathway using
vitamin B-12.
Deficiency signs. The reported signs of nickel depri-
vation for six animal species-chickens, cows, goats,
pigs, rats, and sheep-are extensive and have been listed
in several reviews.127.140,158,159 Unfortunately, the described
signs probably will have to be redefined because recent
studies indicate that many of the reported signs of nickel
deprivation may be manifestations of pharmacological
actions of nickel. 128.160 That is, high dietary nickel was
alleviating an abnormality caused by something other
than nickel deficiency, or changing a variable that was
not necessarily subnormal.
The suggestion that some of the reported signs of nickel
deprivation are misinterpreted manifestations of a phar-
macological action does not necessarily detract from the
conclusion that nickel is an essential element. Several
studies that apparently examined nickel physiologically
indicate that signs of nickel deprivation include depressed
growth, reproductive performance, and plasma glucose
concentrations. Nickel deprivation also affects the dis-
tribution and proper functioning of other nutrients, in-
cluding calcium, iron, zinc, and cobalamin (vitamin B-
12). Also, the nature and severity of nickel deprivation
signs are affected by diet composition and nutritional
stressors. For example, vitamin B-12 deprivation seemed
to depress growth in nickel-supplemented rats but en-
hanced growth in rats depressed by nickel deprivation.
As a result, there was no difference in growth between
nickel-deprived and -supplernented rats fed a diet defi-
cient in vitamin B-12. 156 This and other similar findings
PRESENT KNOWLEDGE IN NUTRITION, 7th Edition
suggest that in higher animals, vitamin B-12 is neces-
sary for the optimal expression of the biological role of
nickel. 157
Requirement. Because of the strong circumstantial
evidence indicating that nickel is essential for several
animals, a reasonable hypothesis is that nickel is also
required by humans. Some animal studies provide some
idea about the amount of nickel possibly required by
humans. Most monogastric animals have a dietary nickel
requirement of <200 llg/kg diet. If it is assumed that adult
humans consume 500 g of a mixed diet daily (dry ba-
sis), then the dietary nickel requirement of humans would
be <100 ug/day. A nickel requirement forhumans of
25-35 ug/day has been suggested.>'
Food and other sources. Total dietary nickel intakes
of humans vary greatly with the amounts and propor-
tions of foods of animal (nickel-low) and plant (nickel-
high) origin consumed. Rich sources of nickel include
chocolate, nuts, dried beans and peas, and grains;123,161-163
diets high in these foods could supply >900 ug nickel!
day. Conventional diets, however, often provide <100
ug/day, Examples of reported intakes are 69-16211g/day
in the United States and 130 ug/day (range 60-260) in
Denmark. 123.163
Excess (toxicity). Life-threatening toxicity of nickel
through oral intake is unlikely. Because of excellent
homeostatic regulation, nickel salts exert their toxic
action mainly by gastrointestinal irritation and not by
inherent toxicity. Generally, ~250 ug nickel/g diet is
required to produce signs of nickel toxicity (such as
depressed growth) in rats, mice, chickens, rabbits, and
monkeys.I64.165 If animal data can be extrapolated to hu-
mans, a daily dose of 250 mg of soluble nickel would
produce toxic symptoms in humans.
Some findings, however, suggest that oral intake of
nickel in moderate doses could adversely affect health
under certain conditions. Moderate amounts of dietary
nickel exacerbate signs of severe iron deficiency and
copper deficiency in rats.127.128.159,160 Nickel may act simi-
larly in humans. Some evidence suggests that the inges-
tion of small amounts of nickel may be more important
than external contacts in maintaining eczema caused by
nickel allergy. An oral dose as low as 0.6 mg nickel as
nickel sulfate given with water to fasting subjects (thus
nickel was highly available) produced a positive reac-
tion in some nickel-sensitive individuals. 166 This dose is
only a few times higher than the human daily require-
ment postulated from animal studies.
Summary. A biochemical function for nickel in higher
animals has not been defined. However, multiple defined
functions in lower forms of life, the response of experi-
mental animals to low dietary intakes, and nickel's dy-
namic stimulation in vitro of some enzymes strongly
suggest that nickel has an essential functional role in
higher animals, including humans.
OTHER TRACE ELEMENTS/Nielsen
Silicon
History. In 1901 it was reported that high concentra-
tions of silicon were present in tendons, aponeuroses,
and eye tissues.v" As early as 1911, researchers suggested
that silicon might have an antiatheroma action.v" Until
1972, however, silicon was generally considered non-
essential, except in some lower classes of organisms
(diatoms, radiolarians, and sponges) in which silica serves
a structural role. In that year, the first substantial evi-
dence was published that silicon is an essential element
for chickens and rats. 169 Most of the limited studies on
the biochemical, nutritional, and physiologic roles of
silicon have been published since 1974.
Chemistry and method ofanalysis. The chemistry of
silicon is similar to that of carbon, its sister element. 170
Silicon forms silicon-silicon, silicon-hydrogen, silicon-
oxygen, silicon-nitrogen, and silicon-carbon bonds. Thus,
organosilicon compounds are analogues of organocarbon
compounds. The substitution of silicon, however, for
carbon, or vice versa, in organocompounds results in
molecules with different properties because silicon is
larger and less electronegative than carbon.
In animals, silicon is found both free and bound. Si-
licic acid probably is the free form. The bound form has
never been rigorously identified. Silicon may be present
in biologic material as a silanolate, an ether (or ester-
like) derivative of silicic acid. R 1-O-Si-O-R2 or R1-O-
Si-O-Si-O-R2 bridges may playa role in the structural
organization of some mucopolysaccharides. 17l
Inductively coupled argon plasma emission and graph-
ite-furnace atomic absorption spectrometric methods have
been used to obtain apparently accurate measures of
silicon in biological materiaL 172-174
Absorption, transport, storage and turnover. Little
is known about the metabolism of silicon." Increasing
silicon intake increases urinary excretion up to fairly
well-defined limits in humans, rats, and guinea pigs.
However, the upper limits of urinary silicon excretion
apparently are not determined exclusively by the ex-
cretory ability of the kidney because urinary excretion
can be elevated above these limits by peritoneal injec-
tions of silicon.!" Thus, the upper limits apparently are
set by the rate and extent of silicon absorption from
the gastrointestinal tract.
The form of dietary silicon determines whether it is
well absorbed. In one studyhumans absorbed only 10%
of a large single dose of an alumina-silicate compound
but absorbed>70% of a single dose of methylsilanetriol
salicylate, a drug used to treat circulatory ischemias and
osteoporosis.!" Further evidence that some forms of
silicon, including those in food, are well absorbed is that
in rats and humans urinary excretion can be a high per-
centage (close to 50%) of daily silicon intake."? Silicon
absorption is affected in rats by age, sex, and the activ-
363
ity of various endocrine glands.'? The mechanisms in-
volved in the intestinal absorption of silicon are unknown.
Connective tissue (including aorta, trachea, tendon,
bone, and skin) and its appendages contain much of the
silicon that is retained in the body.!" The high silicon
content of connective tissues may be the result of its
presence as an integral component of the glycosaminogly-
cans and their protein complexes that contribute to struc-
tural framework.
Silicon is not protein bound in plasma; it is believed
to exist in plasma almost entirely in the undissociated
monomeric silicic acid form, Si(OH)4.169,179 The elimi-
nation of absorbed silicon is mainly via the urine, where
it probably exists as magnesium orthosilicate.vv!"
Physiological (biochemical) function. The distribu-
tion of silicon and the biochemical changes caused by
silicon deprivation in bone indicate that silicon influences
bone formation by affecting cartilage composition and
ultimately cartilage calcification. Silicon is localized in
the active growth areas or the osteoid layer and within
the osteoblasts in young bone of mice and rats. 169,180,181
In bone of silicon-deficient animals, hexosamine (gly-
cosaminoglycans) and collagen concentrations are de-
pressed whereas macromineral composition of bone
mineral is not markedly affected. Extraction and purifi-
cation procedures have shown silicon to be chemically
combined with the glycosaminoglycan fraction of sev-
eral types of connective tissues,169,180,181 Silicon is required
for maximal bone prolylhydroxylase activity, which is
important for collagen formation. 169 Additionally, silicon
was suggested to be involved with phosphorus in the
organic phase in the series of events leading to calcifi-
cation.P" Silicon may be involved in allowing an asso-
ciation between phosphoprotein-mucopolysaccharide
macromolecules and collagen, which playa role in the
initiation of calcification and the regulation of crystal
growth.
The finding that silicon affects gene expression in some
diatoms suggests that a similar role may also exist in
higher animals. 182
Deficiency signs. Most of the signs of silicon defi-
ciency in chickens and rats indicate aberrant metabolism
of connective tissue and bone. 169,180,181 Chicks fed a semi-
synthetic silicon-deficient diet exhibited skull structure
abnormalities associated with depressed collagen content
in bone and long-bone abnormalities characterized by
small, poorly formed joints and defective endochondral
bone growth. Tibias of silicon-deficient chicks exhibit de-
pressed contents of articular cartilage, water, hexosamine,
and collagen. In optimally growing chickens, growth is
not significantly retarded by silicon deficiency. In rats,
humerus hexose is increased and hydroxyproline is de-
creased, plasma amino acid and bone mineral composi-
tion is altered, and femur alkaline and acid phosphatase
are decreased by silicon deprivation. 183-186 Growth of rats
 364
is not markedly affected by silicon deprivation.P'!" Signs
of silicon deprivation can be influenced by low dietary
calcium and high dietary aluminum.P'-"? Rats fed a diet
low in calcium and silicon and high in aluminum accu-
mulated high amounts of aluminum in brain.!"
Requirement. Although a biochemical function for
silicon is unknown, animal findings strongly suggest that
silicon is required by humans. However, postulating a
silicon requirement for humans is difficult because no
appropriate human data and only limited usable animal
data are available. Rats fed about 4.5 mg silicon/kg diet,
mostly as the very available sodium metasilicate, do not
differ from rats fed about 35 mg silicon/kg diet; both
prevent, equally well, silicon deficiency signs exhibited
by rats fed z 1.0 mg silicon/kg diet. 183 Animal diets con-
tain z4000 kcal/kg. The food an average person consumes
daily often contains between 8.37 and 10.46 MJ (2000
and 2500 kcal). Thus, if dietary silicon is highly avail-
able, on the basis of animal data, the human requirement
for silicon is quite small, perhaps in the range of 2-5
mg/day. However, silicon as found in most diets prob-
ably is not absorbable or as available as sodium meta-
silicate; significant amounts probably occur as alumino-
silicates and silica from which silicon is not readily
available. 188 Factors such as aging and low estrogen status
apparently decrease the ability to absorb silicon. 189 Thus,
the recommended intake of silicon may be found to be
between 5 and 10 mg/day.
Food and other sources. Total dietary silicon intake
of humans varies greatly with the amount and propor-
tions of foods consumed and the amounts of refined and
processed foods in the diet. 190,190,191 Normally, refining
reduces the silicon content of foods. However, in recent
years, silicate additives have been increasingly used in
prepared foods and confections as anticaking or anti-
foaming agents. 192 Although this increases total dietary
silicon, most of it is not bioavailable. The silicon con-
tent of drinking water, and beverages made thereof,
shows geographical variation; silicon is high in hard-
water and low in soft-water areas. The richest sources
of silicon are unrefined grains of high fiber content, cereal
products, and root vegetables. 90 ,190,191
Average daily intakes of silicon apparently range from
z20 to 50 mg/day. The calculated silicon content of the
FDA total diet was 19 mg/day for women and 40 mg
for men.'?' A human balance study indicated that the
oral intake of silicon-could be z2l-46 mg/day.!?? The
average British diet was estimated to supply 31 mg
silicon/day. 190
Excess (toxicity). Most silicon compounds are essen-
tially nontoxic when taken orally. Magnesium trisilicate,
an over-the-counter antacid, has been used by humans
for >40 years without obvious deleterious effects. Other
silicates are food additives used as anticaking or anti-
foaming agents.!" However, antioxidant enzymes, includ-
PRESENT KNOWLEDGE IN NUTRITION, 7th Edition
ing superoxide dismutase, catalase, and glutathione per-
oxidase, were reduced in rats fed high amounts of so-
dium metasilicate.!" Additionally, ruminants consuming
plants with a high silicon content may develop siliceous
renal calculi. Renal calculi in humans may also contain
silicates. 169
Summary. Ample circumstantial evidence exists to
indicate that silicon is an essential nutrient for higher
animals, including humans. Findings from animals in-
dicate that silicon nutriture affects macromolecules such
as glycosaminoglycans, collagen, and elastin. Although
more should be known about the physiological or bio-
chemical function and requirement for silicon before
doing so, speculation has materialized on the possible
involvement of silicon deprivation in the occurrence of
several human disorders, including atherosclerosis,
osteoarthritis, osteoporosis, hypertension, and Alzhei-
mer's disease. 90,194 This speculation indicates the need
for more work to clarify the consequences of silicon
deficiency in humans.
Vanadium
History. In 1876, Priestley and Gamgee reported on
the toxicity of sodium vanadate in frogs, pigeons, guinea
pigs, rabbits, dogs, and cats. 195 However, the paper con-
sidered to be the classic for pharmacological and toxi-
cological actions of vanadium appeared in 1912.1% It was
also at this time that high vanadium concentrations were
discovered in the blood of ascidian worms. 197,198 A surge
of interest in vanadium started in 1977 when Cantley et
al. 199 reported that vanadate, which inhibits ATPases, was
a contaminant of commercially available ATP. The in-
terest was maintained subsequently by the finding in the
early 1980s that vanadium is an insulin mimetic agent."?
The first vanadium-containing enzyme, a bromoperox-
idase from the marine alga Ascophyllum nodosum, was
isolated in 1984.201 These in vitro, pharmacological, and
lower-life-form findings have stimulated speculations
about the nutritional importance of vanadium.
The hypothesis that vanadium has an essential role in
higher animals has had a long and inconclusive history.
Findings reported between 1971 and 1974 by four dif-
ferent research groups led many to conclude that vana-
dium is an essential nutrient. 202 However, many of these
findings may have been the consequence of high vana-
dium supplements (10-100 times the amount normally
found in natural diets) that induced pharmacologic
changes in animals fed imbalanced diets. 128,202- 204 The
most substantive evidence for vanadium essentiality has
appeared only since 1987.
Chemistry and methods of analysis. The chemistry
of vanadium is complex because the element can exist
in at least six oxidation states and can form polymers.
In higher animals, the tetravalent and pentavalent valence
OTHER TRACE ELEMENTS/Nielsen
states apparently are the most important forms of vana-
dium. 205,206 The tetravalent state appears most simply as
the vanadyl cation, Y02+, The vanadyl cation behaves
like a simple divalent aquo ion and competes well with
Ca 2+, Mn 2+, Fe 2+, etc., for ligand binding sites. Thus Y02+
easily forms complexes with proteins, especially those
associated with iron, such as transferrin or hemoglobin,
which stabilize vanadyl against oxidation. The pentava-
lent state of vanadium is known as vanadate (H 2V04-
or more simply Y0 3-). Vanadate forms complexes with
other biological substances, including those that result
in it being a phosphate transition-state analogue, and thus
competes with or replaces phosphate in many biochemi-
cal processes, Vanadate is easily reduced by ascorbate,
glutathione, or NADH. For example, with certain cells
(e.g., adipocytes), vanadate enters through nonspecific
anionic channels and is reduced and complexed by glu-
tathione.r"?"
Another form of vanadium has been discussed as be-
ing responsible for many biological actions of vanadium,
including its insulin mimetic action and haloperoxidase
role; this is the peroxo form.209-211 Vanadate can interact
with 0;- formed by NADPH oxidase to generate peroxo-
vanadyl [Y(IY)-OO]. Peroxovanadyl can in tum remove
hydrogen from NADPH to yield vanadyl hydroperox-
ide [Y(IY)-OOH]. Peroxo (hetero-ligand) vanadate ad-
ducts have been suggested to represent a useful model
for the active-site vanadium involved in bromide oxi-
dation in haloperoxidases.?"
Heydom-" reviewed analytical methods for the deter-
mination of vanadium in the low amounts found in tis-
sues, blood, and urine. For this task, especially for hu-
man plasma and serum, methods using atomic emission
spectrometry, particle-induced x-ray emission, flame
atomic absorption spectrometry, and catalysis were found
to be inadequate. Methods that apparently can determine
vanadium accurately in low amounts are electrothermal
atomic absorption spectrometry (ETAAS), neutron ac-
tivation analysis with radiochemical separation (RNAA),
and neutron activation with preirradiation separation
(NAA).213-216 RNAA and NAA are methods not avail-
able to most laboratories; thus, ETAAS is the method
of choice for analysis of samples that have been dry-
ashed, wet-digested, or bomb-digested in a micro-
wave.212-2I4.2I6 As with all trace elements, contamination
of samples is a concern, but apparently for vanadium this
is not as much of a concern as it is for some other trace
elements. 212,214-2I6 ' ferrin.F? Nursing pups absorbed a significant amount of
Absorption, transport, storage, and turnover. Most
ingested vanadium is unabsorbed and is excreted in
the feces. Because very low concentrations of vana-
dium, generally <0.8 ug/L, are found in urine, com-
pared with the estimated daily intake of 12-30 ug and
the fecal content of vanadium, apparently <5% of va-
nadium ingested is normally absorbed. 2l4,m,218 Byrne
365
and Kosta"? estimated that ::;1 % of vanadium normally
ingested with the diet is absorbed. Curran et al. 219 re-
ported that ",0.1-1.0% of vanadium in 100 mg of very
soluble diammonium oxytartarovandate was absorbed
by the human gastrointestinal tract. Animal studies
generally support the concept that vanadium is poorly
absorbed.22-222 However, two studies with rats indicated
that vanadium absorption can exceed 10%.223,224 These
studies suggest caution in assuming that ingested va-
nadium always will be poorly absorbed from the gas-
trointestinal tract. Factors such as fasting and dietary
composition probably had an influence on the percent-
age absorbed from the intestine in these studies.
Kinetic modeling of whole-body vanadium metabo-
lism in sheep indicates that much of vanadium absorbed
is absorbed in the upper gastrointestinal tract.?" Most
ingested vanadium probably is transformed in the stom-
ach to V02+ and remains in this form as it passes into
the duodenum.i" However, in vitro studies suggest that
vanadate can enter cells through phosphate or other anion
transport systems. This may be the reason that Y0 3- is
absorbed 3 to 5 times more effectively than Y02+. Thus,
the different absorbability rates, the effect of other di-
etary components on the forms of vanadium in the stom-
ach, and the speed at which it is transformed into Y02+
apparently markedly affect the percentage of ingested
vanadium absorbed.F" Supporting this concept are the
reviewed findings showing that a number of substances
can ameliorate vanadium toxicity, including ascorbic acid,
EDTA, chromium, protein, ferrous iron, chloride, and
aluminum hydroxide.P"
Based on studies using intravenous or intraperitoneal
injections of the element in animals, vanadium is rap-
idly removed from the blood plasma and is retained in
highest amounts in the kidney, liver, testes, bone, and
spleen. For example, at 96 hours, 30-46% of an intra-
venous dose of 48y was found in the urine and 9-10%
was found in the feces of rats. 227,228 Thirty minutes after
an intraperitoneal injection of 48V, rats retained 7.2% in
the kidney and 2.1 % in bone; at 48 hours, the kidney
retained 1.6% and bone 3.45% of the dose. 222
Much evidence suggests that the binding of the vana-
dyl ion to iron-containing nonheme proteins is impor-
tant in vanadium metabolism. For example, vanadium
in milk of lactating rats injected with 48y was found
mainly in the protein fraction and apparently was asso-
ciated with a transferrin-like protein, perhaps lacto-
the 48y in the milk; this suggests that a lactoferrin-va-
nadium complex is important in vanadium metabolism
in suckling rat pups. In older rats, vanadium apparently
is converted into vanadyl-transferrin and vanadyl-fer-
ritin complexes in plasma and body fluids. 226,227,230,231
One study showed that 1 day after intravenous admin-
istration of 48V02+, 29% of 48y incorporated in rat liver
 366
cytosol existed as a vanadium low-molecular-weight
complex 5000 mol wt).232 By day 9, however, the
low-molecular-weight complex had disappeared and va-
nadium was present only as vanadyl-ferritin (15%) and
vanadyl-transferrin (85%) in rat liver cytosol. It remains
to be determined whether vanadyl-transferrin can trans-
fer vanadium into cells through the transferrin receptor
or whether ferritin is a storage vehicle for vanadium.
Under normal conditions, the body burden of vana-
dium is low (",100f.!g); most tissues contain <10 ng va-
nadium/g wet weight.P' However, tissue vanadium is
markedly elevated in animals fed high dietary vanadium.
In rats, liver vanadium increased from 10 to 55 ng va-
nadium/g wet weight when dietary vanadium was in-
creased from 0.1 to 25 f.!g/g.223 In sheep, bone vanadium
increased from 220 to 3320 ng/g dry weight when di-
etary vanadium was increased from 10 to 270 f.!g/g.233
Thus, bone apparently is a major sink for excessive re-
tained vanadium.
On the basis of studies in which vanadium is ad-
ministered parenterally, urine is the major excretory
route for absorbed vanadium. 224,227,228 Both high- and
low-molecular-weight complexes have been found in
urine;227,228 one of these may be transferrin. A signifi-
cant portion of absorbed vanadium may be excreted
. through the bile. Byrne and Kosta"? found 0.65, 0.55,
and 1.85 ng vanadium/g of human bile. In two stud-
ies, 8-10% of an injected dose of 48y was found in
the feces of rats. 224,228 The form of vanadium in bile
apparently has not been determined.
Physiological (biochemical) function. A defined bio-
chemical function for vanadium in higher animals, and
thus humans, has not been described. Numerous bio-
chemical and physiological functions for vanadium have
been suggested on the basis of its in vitro and pharma-
cological actions; these have been discussed in several
reviews and are too extensive to discuss in detail
here. 206,207,234,235 In vitro studies with cells and pharma-
cological studies with animals have shown that vanadium
has insulin-mimetic properties; numerous stimulatory
effects on cell proliferation and differentiation; effects
on cell phosphorylation-dephosphorylation; inhibitory
effects on the motility of sperm, cilia, and chromosomes;
effects on glucose and ion transport across plasma mem-
branes; interfering effects on intracellular ionized cal-
cium movement; and effects on oxidation-reduction pro-
cesses. In vitro cell-free systems have shown that
vanadium inhibits numerous ATPases, phosphatases, and
phosphoryl transfer enzymes.>' The pharmacological
action of vanadium receiving the most attention recently
is its ability to mimic insulin."? Functional roles for va-
nadium were recently defined for some algae, lichens,
fungi, and bacteria. These roles may provide clues as to
the nature of the actual biochemical role of vanadium
in humans; thus, they are briefly described here.
PRESENT KNOWLEDGE IN NUTRITION, 7th Edition
Haloperoxidases catalyze the oxidation of halide ions
by hydrogen peroxide, thus facilitating the formation of
a carbon-halogen bond. In 1984, vanadium was found
essential to enzymatic activity of a bromoperoxidase from
the brown algae Ascophyllum nodosum.?" Since then,
vanadium-dependent bromoperoxidases have been found
in a number of marine brown algae, marine red algae,
and a terrestrial lichen.Pv'" Vanadium-dependent iodo-
peroxidases were also detected in brown seaweeds, and
a chloroperoxidase was identified in the fungus Curvul-
aria inaequalis,201,236,237
The mechanism of action of vanadium in the haloper-
oxidases has not been firmly established. However, find-
ings to date do not favor a mechanism in which y5+ is
reduced to y4+ or y3+ and reoxidized to v by H20 2.
Rather, in the bromoperoxidases, H20 2 reacts with va-
nadium as y 5+ to form a dioxygen species, which reacts
with bromide to yield an oxidized bromine species, the
intermediate that forms the carbon-halogen bond.i"
Conversion of atmospheric nitrogen to ammonia by
nitrogen-fixing microorganisms is catalyzed by the en-
zyme nitrogenase. Vanadium-dependent nitrogenases
were recently reviewed.P? The reduction of dinitrogen
by nitrogenase involves the sequential MgATP-depen-
dent transfer of electrons from an iron-protein to a va-
nadium-iron-cofactor center at the substrate-binding site
in nitrogenase.
Vanadium is found in high concentrations in some
species of the mushroom genus Amanita. The isolation
and structure determination of a vanadium-containing
compound found in mushrooms and named amavadin
was reviewed.i" The physiological function of amavadin
is unknown but has been suggested to be a cofactor with
a protective oxidase or peroxidase action."! The elec-
trochemistry of amavadin is such that it may function
in electron-transfer reactions through a y5+/y 4+ redox
couple.?"
Deficiency signs. Between 1971 and 1985 several
research groups described possible signs of vanadium
deficiency for some animals.F' However, most of the
early studies were performed with animals fed unbal-
anced diets which resulted in suboptimal health and
growth. The diets used often had widely varied contents
of protein, sulfur-containing amino acids, ascorbic acid,
iron, copper, and perhaps other nutrients that affected,
or were affected by, vanadium metabolism.s" Thus,
pharmacological responses may have been induced by
the high-vanadium supplements fed. As a result, it is
difficult to determine whether the deficiency signs in
early experiments with questionable diets were true de-
ficiency signs, indirect changes caused by an enhanced
need for vanadium in some metabolic function, or mani-
festations of a pharmacological action of vanadium.
Vanadium deficiency signs for humans have not been
described.
Table 1. Ultratrace elements needing further study to confirm nutritional importance o
-I
Apparent deficient Other apparent beneficial I
m
;;0
Element Reported deficiency signs dietary intake or physiological action Dietary sources for humans
-I
;;0
Aluminum (AI) Goat: Increased spontaneous abortions, Goat: 162~g/kg Activates adenylate cyclase;252 Baked goods prepared with
()
depressed growth, incoordination enhances calmodulin activity.-" chemical leavening agents (e.g. m
and weakness in hind legs, and stimulates DNA synthesis in cell baking powder) processed cheese, m
r-
decreased life expectancy-?" culturesr>" stimulates osteoblasts grains, vegetables, herbs, tea, m
to form bone through activating antacids, buffered analgesrcs>" 3:
m
a putative G-protein coupled Z
Chick.Depressed growth": Chick: not given cation sensing systems" -I
~
Z
Bromine (Br) Goat: Depressed growth, fertility, Goat: 0.8 mglkg Alleviates growth retardation caused Grains, nuts, fish 263 !J2...
milk fat production, hematocrit, by hyperthyroidism in mice and (J)
(t)
hemoglobin and life expectancy, chicks;259,260 substitutes for part of :::J

and increased spontaneous chloride requirement for chicks.":

abortions 257,258 insomnia exhibited by many hemodialysis
patients associated with bromide deficit262

Cadmium (Cd) Rat: Depressed growth 264,265 Rat: <4~g/kg Has transforming growth factor activity Shellfish, grains-especially those
or stimulates growth of cells in soft grown on high-cadmium soils,
Goat: Depressed growths" Goat: 20~glkg agar267 leafy vegetables 268

Fluorine (F) Rat: Depressed growth and incisor Rat: 0.04-0.46 mglkg High dietary fluoride improves fertility, Fish, tea, fluoridated water-"
pigmentation"? hematopoiesis and growth in mice
Goat: Depressed growth and life span."? Goat: <0.3 mg/kg and rats;272,273 is anticariogenlc.s"
histological changes in kidney and can be antlosteoporotic.v" prevents
endocrine organs?" phosphorus-induced nephrocalcinosis-">"

Germanium (Ge) Rat: Altered bone and liver mineral Rat: 0.7 mglkg Reverses changes in rats caused by Wheat bran, vegetables,
composition, and decreased silicon deprivation.!" some organic leguminous seeds 263
tibial DNA'84 germanium compounds have antitumor
activit y277,278

Lead (Pb) Rat: Depressed growth, anemia, Rat: 200 ~g/kg279 Alleviates iron deficiency signs in Seafood, plant foodstuffs
disturbed iron metabolism, Rat: 18-45 ~g/kg280-282 young rats 284 grown under high-lead
decreased liver glucose, conditions'?"
triglycerides, LDL-cholesterol
phospholipids, glutamic-oxalic
transaminase activity and glutamic-
pyruvate transaminase activity,
increased liver cholesterol and
alkaline phosphatase activity,
increased serum ceruloplasmin, and
decreased blood catalase279-282
w
0"
Table continues on next page 'I
Table 1. Continued W
0'
00
Apparent deficient Other apparent beneficial
Element Reported deficiency signs dietary intake or physiological action Dietary sources for humans

Pig: Depressed growth, and elevated Pig: 30-32 llglkg

serum cholesterol, phospholipids,
and bile acids283

Lithium (Li) Goat: Depressed fertility, birth weight, Goat: <1.5 mg/kg
life span, liver monoamine oxidase
activity, and serum isocitrate
dehydrogenase, malate dehydrogenase,
aldolase, and glutamate dehydrogenase
activities, and increased serum
creatine kinase activity286
Stimulates growth of some cultured Eggs, meat, processed meat,
cells;l89 exhibits insulinomimetic fish, milk, milk products, potatoes,
actionr'?" incidence of violent crimes vegetables (content varies with
higher in areas with low-lithium geological origi n)286
drinking water.?" hair lithium low
in violent criminals, learning-disabled
subjects, and heart disease patients?"

Rat: Depressed fertility, birth weight, Rat: 0.6-15 ug/kg

litter size, and weaning
weighf 87,288

Rubidium (Rb) Goat: Depressed food intake, growth, Goat: 180 llg/kg Factor R, which prevents hind leg Coffee, black tea, fruits and
and life expectancy, and increased paralysis, swelling of abdomen and vegetables (especially asparagus),
spontaneous abortions'?' death may be rubidiurn-'" poultry, fish 295
-0
;>:l
Tin (Sn) Rat: Depressed growth, alopecia, Rat: 17 llg/kg Influences heme oxygenase Canned foods"?' m
trJ
response to sound, feed efficiency, activity/98,299 associated with thymus m
Z
heart zinc and copper, tibial immune and homeostatic function'?" -l
copper and manganese, muscle A
iron and manganese, spleen iron, Z
kidney iron and lung magnesium; o
increased lung calcium 296,297
:;E
r
m
CJ
om
z
z
C
-I
;;0
=i
6
,z
,...
"
::r
m
a.
;:;:
o':::l
OTHER TRACE ELEMENTS/Nielsen
The uncertainty about vanadium deficiency signs
stimulated new efforts to produce deficiency signs in
animals fed diets apparently containing adequate and
balanced amounts of all known nutrients. Anke et al.242
found that, when compared with controls fed 2 ug va-
nadium/g diet, goats fed <10 ng vanadium/g diet exhib-
ited a higher rate of spontaneous abortion, and animals
that delivered offspring produced less milk during the
first 56 days of lactation. Forty percent of kids from
vanadium-deprived goats died between days 7 and 91
of lactation, with some deaths preceded by convulsions;
only 8% of kids from vanadium-supplemented goats died
during this time. Vanadium-deficient goats had only 55%
the life span of control goats. Also, skeletal deforma-
tions were seen in the forelegs, and forefoot tarsal joints
were thickened.
Uthus and Nielsen-" reported that, when compared
with controls fed 1 ug vanadium/g diet, vanadium dep-
rivation (2 ng vanadium/g diet) increased thyroid weight
and the ratio of thyroid weight to body weight and tended
to decrease growth of rats. Vanadium deprivation also
depressed erythrocyte glucose-6-phosphate dehydroge-
nase and cecal total carbonic anhydrase.t" Uthus and
Nielsen>" also found that, as dietary iodine increased
from 0.05 to 0.33 to 25 ug/g, thyroid peroxidase activ-
ity decreased, and the decrease was more marked in the
vanadium-supplemented than the vanadium-deprived rats.
Also, as dietary iodine increased, plasma. glucose in-
creased in the vanadium-deprived rats but decreased in
the vanadium-supplemented rats. These vanadium-dep-
rivation studies probably have found some true deficiency
signs. It is unlikely the diets lacked any nutrient that
caused such marked deficiency signs, which were pre-
vented by pharmacological action of the small vanadium
supplements used.
Requirement. If vanadium is essential for humans, its
requirement most likely is small. The diets used in ani-
mal deprivation studies contained only 2-25 ng V/g; these
often did not markedly affect the animals. Vanadium
deficiency has not been identified in humans, yet diets
generally supply <30 ug vanadium/day and most sup-
ply only 15 Ilg/day.122,l23,217,218 Thus, a daily dietary in-
take of 10 ug of vanadium probably will meet any pos-
tulated vanadium requirement.
Food and other sources. Foods rich in vanadium in-
clude shellfish, mushrooms, parsley, dill seed, black
pepper, and some preparectfoods. 9o,213,217 Beverages, fats
and oils, and fresh fruits and vegetables contain the least
vanadium 1 to 5 ug/g).
Excess (toxicity). Vanadium is a relatively toxic ele-
ment. The threshold level for toxicity apparently is near
10-20 mg/day, or 10-20 ug/g of diet; this is supported
by animal findings I9S,l96,245 and the following human find-
ings. Schroeder et aI,246 fed 15 patients 4.5 and 9 mg
vanadium/day as diammonium oxytartarovanadate for
369
6-16 months without apparent detrimental effect. How-
ever, serum cholesterol was reduced slightly by the treat-
ment, so the vanadium supplement was not inactive.
Curran et al. 219 fed each of five subjects 13.5 mg/day in
three divided doses as diammonium oxytartarovanadate
for 6 weeks; no sign of intolerance or toxicity was found.
Somerville and Davies-" gave each of 12 patients 13.5
mg vanadium/day for 2 weeks and then 22.5 mg vana-
dium/day for 5 months; five patients exhibited gas-
trointestinal disturbances and five patients exhibited green
tongue. Dimond et al,248 gave ammonium vanadyl tar-
trate orally to six subjects for 6-10 weeks in amounts
ranging from 4.5 to 18 mg vanadium/day; green tongue,
cramps, and diarrhea were observed at the larger doses.
From their in-depth study of vanadium toxicity, Proe-
scher et al.249 concluded that vanadium is a neurotoxic
and hemorrhagic-endotheliotoxic poison with nephro-
toxic, hepatotoxic, and probably leukocytotoxic compo-
nents. Thus, it is not surprising that a variety of toxic-
ity signs exist and that they can vary among species and
with dosage. Some of the more consistent signs include
depressed growth, diarrhea, depressed food intake, and
death.
Summary. Although it has numerous in vitro and
pharmacological properties that suggest essentiality, the
importance of vanadium in nutrition remains to be de-
termined. Identification of a specific biochemical role
for vanadium is necessary to disentangle pharmacological
from nutritional observations to assess the nutritional
importance of vanadium and to determine its safe and
adequate intakes. Because vanadium is so pharmacologi-
cally active, a beneficial pharmaceutical role for this
element may be found.
Other Elements
As indicated in the introduction, the evidence for es-
sentiality of aluminum, bromine, cadmium, fluorine,
germanium, lead, lithium, rubidium, and tin is quite lim-
ited. Findings that have led to some researchers suggest-
ing that these elements are essential are summarized in
Table 1.
References
1. Nielsen FH (1984) Ultratrace elements in nutrition. Annu
Rev Nutr 4:21-41
2. Gorby MS (1994) Arsenic in human medicine. In Nriagu JO
(ed), Arsenic in the environment, Part II: Human health and
ecosystem effects. Wi ley, New York, pp 1-16
3. Coulson El, Remington RE, Lynch KM (1935) Metabolism
in the rat of the naturally occurring arsenic in shrimp as
compared with arsenic trioxide. J Nutr 10:255-270
4. Hove E, Elvehjem CA, Hart EB (1938) Arsenic in the nutri-
tion of the rat. Am J Physiol 124:205-212
5. Nielsen FH, Uthus EO (1984) Arsenic. In Frieden E (ed),
370
Biochemistry of the essential ultratrace elements. Plenum,
New York, pp 319-340
6. Shiomi K (1994) Arsenic in marine organisms: chemical forms
and toxicological aspects. In Nriagu JD (ed), Arsenic in the
environment, Part II: Human health and ecosystems effects.
Wiley, New York, pp 261-282
7. Dhubhghaill OMN, Sadler PJ (1991) The structure and re-
activity of arsenic compounds: biological activity and drug
design. Struct Bond 78:129-190
8. Uthus EO, Collings ME, Cornatzer WE, Nielsen FH (1981)
Determination of total arsenic in biological samples by ar-
sine generation and atomic absorption spectrometry. Anal
Chem 53 :2221-2224
9. Wang Wj, Hanamura 5, Winefordner JD (1986) Determina-
tion of arsenic by hydride generation with a long absorp-
tion cell for atomic absorption spectrometry. Anal Chim Acta
184:213-218
10. Vahter M (1983) Metabolism of arsenic. In Fowler BA (ed),
Biological and environmental effects of arsenic. Elsevier,
Amsterdam, pp 171-198
11. Marafante E, Vahter M (1987) Solubil ity, retention, and
metabolism of intratracheally and orally administered inor-
ganic arsenic compounds in the hamster. Environ Res
42:72-82
12. Yamauchi H, Kaise T, Yamamura Y (1986) Metabolism and
excretion of orally administered arsenobetaine in the ham-
ster. Bull Environ Contam Toxicol 36:350-355
13. Marafante E, Vahter M, Dencker L (1984) Metabolism of
arsenocholine in mice, rats and rabbits. Sci Total Environ
34:223-240
14. Yamauchi H, Yamamura Y (1984) Metabolism and excre-
tion of orally administered dimethylarsinic acid in the ham-
ster. Toxicol Appl Pharmacol 74:134-140
15. McChesney EW, Hoppe JO, McAuliff P, Banks WF [r (1962)
Toxicity and physiological disposition of sodium p-N-
glycolylarsanilate. I. Observations in mouse, cat, rat and man.
Toxicol Appl Pharmacol 4:14-23
16. Fullmer CS, Wasserman RH (1985) Intestinal absorption of
arsenate in the chick. Environ Res 36:206-217
17. Hwang SW, Schanker LS (1973) Absorption of organic ar-
senical compounds from the rat small intestine. Xenobiotica
3:351-355
18. Yamauchi H, Takahashi K, Mashiko M, et al (1992) Intake
of different chemical species of dietary arsenic by the Japa-
nese, and their blood and urinary arsenic levels. Appl
Organomet Chem 6:383-388
19. Vahter M, Envall H (1983) In vivo reduction of arsenate in
mice and rabbits. Environ Res 32:14-24
20. Thompson DJ (1993) A chemical hypothesis for arsenic
methylation in mammals. Chem Bioi Interact 88:89-114
21. Marafante E,Vahter M (1984) The effect of methyltransferase
inhibition on the metabolism of C4 As) arsenite in mice and
rabbits. Chem Bioi Interact 50:49-57
22. Buchet JP, Lauwerys R (1985) Study of inorganic arsenic
methylation by rat liver in vitro: relevance for the interpre-
tation of observations in. man. Arch Toxicol 57:125-129
23. Buchet JP, Lauwerys R (1987) Study of factors influencing
the in vivo methylation of inorganic arsenic in rats. Toxicol
Appl Pharmacol 91 :65-74
24. Vahter M, Marafante E (1987) Effects of low dietary intake
of methionine, choline or proteins on the biotransformation
of arsenite in the rabbit. Toxicol Lett 37:41-46
25. Vahter M, Marafante E, Dencker L (1983) Metabolism of
arsenobetaine in mice, rats and rabbits. Sci Total Environ
30:197-211
26. Yamauchi H, Yamamura Y (1983) Concentration and cherni-
PRESENT KNOWLEDGE IN NUTRITION, 7th Edition
cal species of arsenic in human tissue. Bull Environ Contam
Toxicol 31:267-270
27. Lanz H Ir, Wallace PC, Hami Iton JG (1950) The metabo-
lism of arsenic in laboratory animals with As'4 as a tracer.
Univ Calif Publ Pharmacol 2:263-282
28. Vahter M, Marafante E, Lindgren A, Dencker L (1982) Tis-
sue distribution and subcellular binding of arsenic in mar-
moset monkeys after injection of 74As-arsenite. Arch Toxicol
51 :65-77
29. Vahter M, Marafante E (1985) Reduction and binding of
arsenate in marmoset monkeys. Arch Toxicol 57:119-124
30. Tam GKH, Charbonneau SM, Bryce F, et al (1979) Metabo-
lism of inorganic arsenic C4 As) in humans following oral
ingestion. Toxicol Appl Pharmacol 50:319-322
31. Yamato N (1988) Concentrations and chemical species of
arsenic in human urine and hair. Bull Environ Contam Toxicol
40:633-640
32. Uthus EO (1992) Evidence for arsenic essentiality. Environ
Geochem Health 14:55-58
33. Desrosiers R, Tanguay RM (1986) Further characterization
of the posttranslational modifications of core histones in
response to heat and arsenite stress in Drosphilia. Biochem
Cell Bioi 64:750-757
34. van Bergen en Henegouwen PMp, Linnemans WAM (1987)
Heat shock gene expression and cytoskeletal alterations in
mouse neuroblastoma cells. Exp Cell Res 171 :367-375
35. Nielsen FH (1988) Possible future implications of ultratrace
elements in human health and disease. In Prasad AS (ed),
Essential and toxic trace elements in human health and
disease. Current Topics in Nutrition and Disease, Vol 18.
l.iss, New York, pp 277-292
36. Meng Z, Meng N (19 q4) Effects of inorganic arsenicals on
DNA synthesis in unsensitized human blood lymphocytes
in vitro. Bioi Trace Elem Res 42:201-208
37. Meng Z (1993) Effects of arsenic on DNA synthesis in hu-
man lymphocytes stimulated by phytohemagglutinin. Bioi
Trace Elem Res 39:73-80
38. Anke M (1986) Arsenic. In Mertz W (ed), Trace elements in
human and animal nutrition, Vol 2. Academic Press, Orlando,
FL, pp 347-372
39. Schmidt A, Anke M, Groppel B, Kronemann H (1984) Ef-
fects of As-deficiency on skeletal muscle, myocardium and
liver. A histochemical and ultrastructural study. Exp Pathol
25:195-197
40. Uthus EO (1994) Diethyl maleate, an in vivo chemical
depletor of glutathione, affects the response of male and
female rats to arsenic deprivation. Bioi Trace Elem Res
46:247-259
41. Mayer DR, Kosmus W, Pogglitsch H, et al (1993) Essential
trace elements in humans. Serum arsenic concentrations in
hemodialysis patients in comparison to healthy controls. Bioi
Trace Elem Res 37:27-38
42. Uthus EO, Nielsen FH (1993) Determination of the possible
requirement and reference dose levels for arsenic in humans.
Scand J Work Environ Health 19(suppl 1):137-138
43. Uthus EO (1994) Estimation of safe and adequate daily in-
take for arsenic. In Mertz W, Abernathy CO, Olin 55 (eds),
Risk assessment of essential elements. ILSI Press, Washing-
ton, DC, pp 273-282
44. Evans WH, Sherlock JC (1987) Relationships between el-
emental intakes within the United Kingdom total diet study
and other adult dietary studies. Food Addit Contam 4:1-8
45. Buchet JP, Lauwerys R, Vandevoorde A, Pycke JM (1983)
Oral daily intake of cadmium, lead, manganese, copper,
chromium, mercury, calcium, zinc, and arsenic in Belgium:
a duplicate meal study. Food Chern Toxicol 21 :19-24
OTHER TRACE ELEMENTS/Nielsen
46. Mykkanen H, Rasanen L, Ahola M, Kimppa S (1986) Di-
etary intakes of mercury, lead, cadmium, and arsenic by
Finnish children. Hum Nutr Appl Nutr 40A:32-39
47. Vallee BL, Ulmer DO, Wacker WEC (1960) Arsenic toxicol-
ogy and biochemistry. AMA Arch Ind Health 21 :132-151
48. Kaise T, Watanabe S, Itoh K (1985) The acute toxicity of
arsenobetaine. Chemosphere 14:1327-1332
49. Kaise T, Horiguchi Y, Fukui S, et al (1992) Acute toxicity
and metabolism of arsenocholine in mice. Appl Organometal
Chem 6:369-373
50. Squibb KS, Fowler BA (1983) The toxicity of arsenic and its
compounds. In Fowler BA (ed), Biological and environmental
effects of arsenic. Elsevier, Amsterdam, pp 233-269
51. Ishinishi N, Tsuchiya K, Vahter M, Fowler BA (1986) Arsenic.
In Friberg L, Nordberg GF, Vouk V (eds), Handbook on the
toxicology of metals, 2nd ed. Elsevier, Amsterdam, pp 43-83
52. Morton WE, Dunnette DA (1994) Health effects of environ-
mental arsenic. In Nriagu JO (ed), Arsenic in the environ-
ment, Part II: Human health and ecosystem effects. Wiley,
New York, pp 17-34
53. Goldman M, Dacre JC (1991) Inorganic arsenic compounds:
are they carcinogenic, mutagenic, teratogenic? Environ
Geochem Health 13:179-191
54. Wiley HW (1904) Influence of food preservatives and arti-
ficial colors on digestion and health. I. Boric acid and bo-
rax. US Department of Agriculture Bulletin No. 84, Pt. 1.
Government Printing Office, Washington, DC
55. Warrington K (1923) The effect of boric acid and borax on
the broad bean and certain other plants. Ann Bot 37:629-672
56. Hove E, Elvehjem CA, Hart EB (1939) Boron in animal
nutrition. Am J Physiol 127:689-701
57. Orent-Keiles E (1941) The role of boron in the diet of the
rat. Proc Soc Exp Bioi Med 44:199-202
58. Teresi JD, Hove E, Elvehjem CA, Hart EB (1944) Further study
of boron in the nutrition of rats. Am J Physiol 140:513.-518
59. Skinner [T, McHargue JS (1945) Response of rats to boron
supplements when fed rations low in potassium. Am J Physiol
143:385-390
60. Follis RH [r (1947) The effect of adding boron to a potas-
sium-deficient diet in the rat. Am J Physiol 150:520-522
61. Hunt CD, Nielsen FH (1981) Interaction between boron and
cholecalciferol in the chick. In McC Howell J, Gawthorne
JM, White CL (eds), Trace element metabolism in man and
animals, TEMA-4. Australian Academy of Science, Canberra,
Australia, pp 597-600
62. Woods WG (1994) An introduction to boron: history, sources,
uses and chemistry. Environ Health Perspect 102(suppl
7):5-11
63. Zittle CA (1951) Reaction of borate with substances of bio-
logical interest. Adv Enzymol 12:493-527
64. Lindquist R, Terry C (1974) Inhibition of subtilisin by bo-
ronic acids, potential analogs of tetrahedral reaction inter-
mediates. Arch Biochem Biophys 160:135-144
65. Chen TSS, Chang C-j, Floss HG (1980) Biosynthesis of the
boron-containing antibiotic aplasmomycin. Nuclear mag-
netic resonance analysisof aplasmomycin and desboroa-
plasmomycin. J Antibiotics 33:1316-1322
66. Dunitz JD, Hawley OM, Miklos 0, et al (1971) Structure of
boromycin. Helv Chim Acta 54:1709-1713
67. Hunt CD, Shuler TR (1989) Open-vessel, wet-ash, tow-tern-
perature digestion of biological materials for inductively
coupled argon plasma spectroscopy (ICAP) analysis of bo-
ron and other elements. J Micronutr Anal 6:161-174
68. Ferrando AA, Green NR, Barnes KW, Woodward B (1993)
Microwave digestion preparation and ICP determination of
boron in human plasma. Bioi Trace Elem Res 37:17-25
371
69. Iyengar GV, Clarke WB, Downing RG (1990) Determina-
tion of boron and lithium in diverse biological matrices using
neutron activation-mass spectrometry (NA-MS). Fresenius J
Anal Chem 338:562-566.
70. Vanderpool RA, Hoff 0, Johnson PE (1994) Use of induc-
tively coupled plasma-mass spectrometry in boron-1 0 stable
isotope experiments with plants, rats and humans. Environ
Health Perspect 102(suppl 7):13-20
71. Kent NL, McCance RA (1941) The absorption and excre-
tion of "minor" elements by man. I. Silver, gold, lithium,
boron, and vanadium. Biochem J 35:837-844
72. Jansen JA, Schou JS, Aggerbeck B (1984) Gastro-intestinal
absorption and in vitro release of boric acid from water-
emulsifying ointments. Food Chem Toxicol 22:49-53
73. Havercroft JM, Ward NI (1991) Boron and other elements
in relation to.rheumatoid arthritis. In Momeilovic B (ed), Trace
elements in man and animals 7. IMI, Zagreb, pp 8.2-8.3
74. ShulerTR, Pootrakul P, Yarnsukon P, Nielsen FH (1990) Effect
of thalassemia/hemoglobin E disease on macro, trace, and
ultratrace element concentrations in humans tissues. JTrace
Elem Med 3 :31-43
75. Abou-Shakra FR, HavercroftJM, Ward NI (1989) Lithium and
boron in biological tissues and fluids. Trace Elem Med
6:142-146
76. Hunt CD (1989) Dietary boron modified the effects of mag-
nesium and molybdenum on mineral metabolism in the
cholecalciferol-deficient chick. Bioi Trace Elem Res
22:201-220
77. Hunt CD (1994) The biochemical effects of physiologic
amounts of dietary boron in animal nutrition models. Environ
Health Perspect 102(suppl 7):35-43
78. Loomis WD, Durst RW (1992) Chemistry and biology of
boron. BioFactors 3:229-239
79. Blevins DG, Lukaszewski KM (1994) Proposed physiologic
functions of boron in plants pertinent to animal and human
metabolism. Environ Health Perspect 102(suppl 7):31-33
80. Nielsen FH (1991) Nutritional requirements for boron, sili-
con, vanadium, nickel and arsenic: current knowledge and
speculation. FASEB J 5:2661-2667
81. Nielsen FH (1994) Biochemical and physiologic conse-
quences of boron deprivation in humans. Environ Health
Perspect 102(suppl 7):59-63
82. Nielsen FH (1991) The saga of boron in food: from a ban-
ished food preservative to a beneficial nutrient for humans.
Curr Top Plant Biochem Physiol 10:274-286
83. Penland JG (1990) Dietary boron affects brain function in
mature Long-Evans rats. Proc NO Acad Sci 44:78
84. Hegsted M, Keenan Mj, Siver F, Wozniak P (1991) Effect of
boron on vitamin 0 deficient rats. Bioi Trace Elem Res
26:243-255
85. Nielsen FH (1989) Dietary boron affects variables associ-
ated with copper metabolism in humans. In Anke M,
Baumann W, Braunlich H, et al (eds), 6th International Trace
Element Symposium, 1989, Vol 4. Friedrich-Schiller-
Universitat, lena, pp 1106-1111
86. Nielsen FH, Mullen LM, Gallagher SK (1990) Effect of bo-
ron depletion and repletion on blood indicators of calcium
status in humans fed a magnesium-low diet. J Trace Elem
Exp Med 3:45-54
87. Nielsen FH, Mullen LM, Nielsen EJ (1991) Dietary boron
affects blood cell counts and hemoglobin concentrations
humans. J Trace Elem Exp Med 4:211-223
88. Nielsen FH, Gallagher SK, Johnson LK,
Boron enhances and mimics some
therapy in postmenopausal women. J
5:237-246
372
89. Penland JG (1994) Dietary boron, brain function, and cog-
nitive performance. Environ Health Perspect 102(suppl
7):65-72
90. Nielsen FH (1988) The ultratrace elements. In KT Smith (ed),
Trace minerals in foods. Marcel Dekker, New York, pp
357-428
91. Hunt CD (1988) Boron homeostasis in the cholecalciferol-
deficient chick. Proc ND Acad Sci 42:60.
92. Hunt CD, Shuler TR, Mullen LM (1991) Concentration of
boron and other elements in human foods and personal-
care products. J Am Diet Assoc 91 :558-568
93. Anderson DL, Cunningham WC, Lindstrom TR (1994) Con-
centrations and intakes of H, B, S, K, Na, CI, and NaCI in
foods. J Food Comp Anal 7:59-82
94. Clarke WB, Gibson RS (1988) Lithium, boron, and nitrogen
in 1-day diet composites and a mixed-diet standard. J Food
Comp Anal 1:209-220
95. Green GH, Lott MD, Weeth HJ (1973) Effects of boron-water
on rats. Proc West Sec Am Soc Anim Sci 24:254-258
96. Seal BS, Weeth HJ (1980) Effect of boron in drinking water
on the male laboratory rat. Bull Environ Contam Toxicol
25:782-789
97. Franke I. Runge H, Bech R, et al (1985) Boron as an anti-
dote to fluorosis? Part 1. Studies of the skeletal system. Fluo-
ride 18:187-197
98. Health effects of boron. (1994) Environ Health Perspect
102(suppl 7)
99. Linden CH, Hall AH, Kulig KW, Rumack BH (1986) Acute
ingestions of boric acid. Clin Toxicol 24:269-279
100. Pinto j, HuangYP, McConnell Rl. Rivlin RS (1978) Increased
urinary riboflavin excretion resulting from boric acid inges-
tion. J Lab Clin Med 92:126-134
101. Gordon AS, Prichard JS, Freedman MH (1973) Seizure dis-
orders and anemia associated with chronic borax intoxica-
tion. Can Med Assoc J 108:719-721
102. Mills CF, Davis GK(1987) Molybdenum. In Mertz W (ed),
Trace elements in human and animal nutrition, Vol 1. Aca-
demic Press, San Diego, pp 429-463
103. Rajagopalan KV (1988) Molybdenum: an essential trace
element in human nutrition. Annu Rev Nutr 8:401-427
104. Rajagopalan KV (1984) Molybdenum. In Frieden E (ed),
Biochemistry of the essential ultratrace elements. Plenum,
New York, pp 149-1 74
105. Rajagopalan KV (1988) Molybdopterin-problems and per-
spectives. BioFactors 1:273-278
106. Wootton ]C, Nicolson RE, Cock JM, et al (1991) Enzymes
depending on the pterin molybdenum cofactor: sequence
families, spectroscopic properties of molybdenum and pos-
sible cofactor-binding domains. Biochim Biophys Acta
1057:157-185
107. Winston PW (1981) Molybdenum. In Bronner F, Coburn JW
(eds), Disorders of mineral metabolism, Vol. 1, Trace min-
erals. Academic Press, New York, pp 295-315
108. Ward AF, Marciello LF, Carrara L, Luciano VJ (1980) Simul-
taneous determination of major, minor, and trace elements
in agricultural and bioJogical samples by inductively coupled
argon plasma spectrometry. Spect Lett 13:803-831
109. Turnlund JR, Keyes WR, Pfeiffer GL (1993) A stable isotope
study of the dietary molybdenum requi rement of young men.
In Anke M, Meissner D, Mills CF (eds), Trace elements in
man and animals, TEMA-8. Verlag Media Touristik, Gersdorf,
pp 189-193
110. Cardin C], Mason J (1976) Molybdate and tungstate trans-
fer by rat ileum. Competitive inhibition by sulphate. Biochim
Biophys Acta 455:937-946
111. Kosarek l], Winston PW (1977) Absorption of molybdenum-
PRESENT KNOWLEDGE IN NUTRITION, 7th Edition
99 (Mo-99) as molybdate with various doses in the rat [ab-
stract]. Fed Proc 36:1106
112. Lener J, Bibr B (1984) Effects of molybdenum on the organ-
ism (a review). J Hyg Epidemiol Microbiol Immunol
28:405-419
113. Grace ND, Martinson PL (1985) The distribution of Mo
between the liver and other organs and tissues of sheep
grazing a ryegrass white clover pasture. In Mills CF, Bremner
I, ChestersJK (eds), Traceelements in man and animals, TEMA
5. Commonwealth Agricultural Bureaux, Farnham Royal, pp
534-536
114. Beedham C (1985) Molybdenum hydroxy lases as drug-
metabolizing enzymes. Drug Metab Rev 16:119-156
115. Blanchardie P, Lustenberger P, Orsonneau JL, et al (1984)
Influence of molybdate, ionic strength and pH on ligand
binding to the glucocorticoid receptor. Steroids 44:159-174
116. Bodine PY, Litwack G (1988) Evidence that the modulator
of the glucocorticoid-receptor complex is the endogenous
molybdate factor. Proc Natl Acad Sci USA 85:1462-1466
117. Mills CF, Bremner I (1980) Nutritional aspects of molybde-
num in animals. In Coughlan MP (ed), Molybdenum and
molybdenum-containing enzymes. Pergamon, Oxford, pp
517-542
118. Anke M, Risch MA (1989) Importance of molybdenum in
animal and man. In Anke M, Baumann W, Braunlich H, et
al (eds), 6th International Trace Element Symposium, Mo-
lybdenum, Vanadium. Friedrich-Schiller-Universitat, lena, pp
303-321b
119. Abumrad NN, Schneider Aj, Steel D, Rogers LS(1981) Amino
acid intolerance during prolonged total parenteral nutrition
reversed by molybdate therapy. Am J Clin Nutr 34:2551-2559
120. Wang X, Oberleas D, Yang MT, Yang SP (1992) Molybde-
num requirement of female rats. J Nutr 122:1036-1041
121. National Research Counci I (1989) Recommended dietary
allowances, 10th ed. National Academy Press, Washington,
DC
122. Evans WH, Read JI, Caughlin D (1985) Quantification of
results for estimating elemental dietary intakes of lithium,
rubidium, strontium, molybdenum, vanadium, and silver.
Analyst 110:873-877
123. Pennington JAT, Jones JW (1987) Molybdenum, nickel, co-
balt, vanadium, and strontium in total diets. JAm DietAssoc
87:1644-1650
124. Shiraishi K, Yamagami Y, Kameoka K, Kawamura H(1988)
Mineral contents in model diet samples for different age
groups. J Nutr Sci Vitaminol (Tokyo) 34:55-65
125. Glei M, Anke M, Muller M, Losch E (1994) Molybda-
naufnahme und Molybdanbilanz Erwachsener in Deutsch-
land. In Anke M, Meissner D, Bergmann H, et al (eds),
Defizite und Oberschusse an Mengen-und Spurenelementen
in der Ernahrung. 14. Arbeitstagung Mengen-und Spurenele-
mente 1994. Verlag Harald Schubert, Leipzig, pp 251-256
126. Anke M, Losch E, Glei M, et al (1993) Der Molybdangehalt
der Lebensmittel und Getranke Deutschlands. In Anke M,
Bergmann H, Bitsch R, et al (eds), Mengen-und Spurenele-
mente. 13. Arbeitstagung 1993. Verlag MTV Hammerschmidt,
Gersdorf, pp 537-553
127. Nielsen FH (1984) Nickel. In Frieden E (ed), Biochemistry
of the essential ultratrace elements. Plenum, New York, pp
293-308
128. Nielsen FH (1985) The importance of diet composition in
ultratrace element research. J Nutr 115:1239-1247
129. Sunderman FW Jr (1977) A review of the metabolism and
toxicology of nickel. Ann Clin Lab Sci 1:377-398
130. Nieboer E, Tom RT, Sanford WE (1988) Nickel metabolism
in man and animals. In Sigel H, Sigel A (eds), Metal ions in
OTHER TRACE ELEMENTS/Nielsen
biological systems, Vol 23, Nickel and its role in biology.
Marcel Dekker, New York, pp 91-121
131. Tabata M, Sarkar B (1992) Specific nickel (Ill-transfer pro-
cess between the native sequence peptide representing the
nickel (II)-transport site of human albumin and L-histidine.
J Inorg Biochem 45:93-104
132. Andrews RK, Blakely RL, Zerner B (1988) Urease-a Ni (II)
metalloenzyme. In Lancaster JR Ir (ed), The bioinorganic
chemistry of nickel. VCH, New York, pp 141-165
133. Walsh CT, Orrne-lohnson WH (1987) Nickel enzymes. Bio-
chemistry 26:4901-4906
134. Thauer RK (1985) Nickelenzyme im Stoffwechsel von
methanogenen Bakterien. Bioi Chem Hoppe Seyler
366:103-112
135. Hausinger RP (1987) Nickel utilization by microorganisms.
Microbiol Rev 51 :22-42
136. Sunderman FW Jr, Hopfer SM, Crisostomo MC (1988) Nickel
analysis by electrothermal atomic absorption spectrometry.
Methods Enzymol 158:382-391
137. Solomons NW, Viteri F, Shuler TR, Nielsen FH (1982)
Bioavailability of nickel in man. Effects of foods and chemi-
cally-defined dietary constituents on the absorption of in-
organic nickel. J Nutr 112:39-50
138. Sunderman FW Jr, Hopfer SM, Swift 1; et al (1988) Nickel
absorption and elimination in human volunteers. In Hurley
LS, Keen CL, l.onnerdal B, Rucker RB (eds), Trace elements
in man and animals 6. Plenum, New York, pp 427-428
139. Nielsen FH (1983) Studies on the interaction between nickel
and iron during intestinal absorption. In Anke M, Baumann
W, BraLinlich H, Bruckner C (eds), 4 Spurenelement-Sym-
posium. Friedrich-Schiller-Universitat, lena, pp 11-18
140. Kirchgessner M, Roth-Maier DA, Schnegg A (1981) Progress
of nickel metabolism and nutrition research. In McHowell
J, Gawthorne JM, White CL (eds), Trace element metabo-
lism in man and animals, TEMA 4. Australian Academy of
Science, Canberra, Austral ia, pp 621-624
141. Kirchgessner M, Roth-Maier DA, Sporl R (1983) Spurenele-
mentbilanzen (Cu. Zn, Ni, und Mn) laktierender Sauen. Z
Tierphysiol Tierernhr Futtermittelkd 50:230-239
142. Becker G, Dorstelrnann U, Frommberger U, Forth W (1980)
On the absorption of cobalt (11)- and nickel (Ill-ions by iso-
lated intestinal segments in vitro of rats. In Anke M, Schneider
H-j, Bruckner C (eds), 3 Spurenelement-Symposium, Nickel.
Friedrich-Schiller-Universitat, lena, pp 79-85
143. Foulkes EC, McMullen DM (1986) On the mechanism of
nickel absorption in the rat jejunum. Toxicology 38:35-42
144. Nielsen FH (1980) Effect of form of iron on the interaction
between nickel and iron in rats: growth and blood param-
eters. J Nutr 110:965-973
145. Iasirn S, Tjiilve H (1986) Effect of sodium pyridinethione on
the uptake and distribution of nickel, cadmium, and zinc
in pregnant and non-pregnant mice. Toxicology 38:327-350
146. Nomoto S, Sunderman FW [r (1988) Presence of nickel in
alpha-2 macroglobulin isolated from human serum by high
performance liquid chromatography. Ann Clin Lab Sci
18:78-84
147. Rezuke WN, Knight JA, Sunderman FW [r (1987) Reference
values for nickel concentrations in human tissue and bile.
Am J Ind Med 11:419-426
148. Predki PF, Whitfield DM, Sarkar B (1992) Characterization
and cellular distribution of acidic peptide and oligosaccha-
ride metal-binding compounds from kidneys. Biochem J
281:835-841
149. Sunderman FW [r, Mangold BLK, Wong SHY, et al (1983)
High-performance size-exclusion chromatography of
63Ni-consitituents in renal cytosol and microsomes from
373
63NiCI2-tlt~ated rats. Res Commun Chem Pathol Pharmacol
39:477-492
150. Cohn JR, Emmett EA (1978) The excretion of trace metals
in human sweat. Ann Clin Lab Sci 8:270-275
151. Przybyla AE, Robbins L Menon N, Peck HD [r (1992) Struc-
ture-function relationships among the nickel-containing
hydrogenases. FEMS Microbiol Rev 88:109-136
152. Kim H, Yu C, Maier RJ (1991) Common cis-acting region
responsible for transcriptional regulation of Bradyrhizobium
japonicum hydrogenase by nickel, oxygen, and hyrogen. J
Bacteriol 173:3993-3999
153. Diekert G (1988) Carbon monoxide dehydrogenase of
acetogens. In Lancaster JR Ir (ed), The bioinorganic chem-
istry of nickel. VCH, New York, pp 299-309
154. Ragsdale SW, Wood HG, Morton TA, et al (1988) Nickel in
CO dehydrogenase. In Lancaster JRIr (ed), The bioinorganic
chemistry of nickel. VCH, New York, pp 311-332
155. Bible KC, Buytendorp M, Zierath PD, Rinehart KL (1988)
Tunichlorin: A nickel chlorin isolated from the Caribbean
tunicate Trididemnum solidum. Proc Natl Acad Sci USA
85:4582-4586
156. Nielsen FH, Zimmerman T], Shuler TR, et al (1989) Evidence
for a cooperative metabolic relationship between nickel and
vitamin B'2 in rats. J Trace Elem Exp Med 2:21-29
157. Nielsen FH, Uthus EO, Poellot RA, Shuler TR (1993) Di-
etary vitamin B12 , sulfur amino acids, and odd-chain fatty
acids affect the response of rats to nickel deprivation. Bioi
Trace Elem Res 37:1-15
158. Anke M, Groppel B, Kronemann H, Grun M (1984) Nickel-
an essential element. In Sunderman FW (ed), Nickel in the
human environment. International Agency for Research of
Cancer, Lyon, pp 339-365
159. SpearsJW (1984) Nickel as a "newer trace element" in the
nutrition of domestic animals. J Anim Sci 59:823-835
160. Nielsen FH, Shuler TR, Mcleod TG, Zimmerman TJ (1984)
Nickel influences iron metabolism through physiologic,
pharmacologic and toxicologic mechanisms in the rat. J Nutr
114:1280-1288
161. Anke M, Angelow L, Muller M, Glei M (1993) Dietary trace
element intake and excretion of man. In Anke M, Meissner
D, Mills CF (eds),Trace elements in man and animals, TEMA
8. Verlag Media Touristik, Gersdorf, pp 180-188
162. Flyvholm M-A, Nielsen GD, Andersen A (1984) Nickel
content of food and estimation of dietary intake. Z Lebensm
Unters Forsch 179:427-431
163. Veien NK, Anderson MR (1986) Nickel in Danish food. Acta
Derm Venereol (Stockh) 66:502-509
164. Kirchgessner M, Reichlmayr-Lais A, Maier R (1985) Ni reten-
tion and concentrations of Fe and Mn in tissuesresulting from
different Ni supply. In Mills CF, Bremner I, Chesters JK(eds),
Traceelements in man and animals, TEMA 5. Commonwealth
Agricultural Bureaux, Farnham Royal, pp 147-151
165. Nielsen FH (1977) Nickel toxicity. In Goyer RA, Mehlman
MA (eds), Advances in modern toxicology: Toxicology of
trace elements, Vol 2. Wiley, New York, pp 129-146
166. Cronin E, Di Michiel AD, Brown SS (1980) Oral challenge
in nickel-sensitive women with hand eczema. In Brown SS,
Sunderman FW [r (eds), Nickel toxicology. Academic Press,
New York, pp 149-152
167. Schulz H (1901) Uber den Kieselsauregehalt menschlicher
und thierischer Gewebe. PflugersArch Ges PhysioI84:67-1 00
168. Gouget MA (1911) Atherorne experimental et silicate de
soude. La Presse Medicale 97:1005-1006
169. Carlisle EM (1984) Silicon. In Frieden E
of the essential ultratrace elements. Plenum,
257-291
374
170. Wannagat U (1978) Sila-pharmaca. Nobel Symp 40:447-472
171. Schwarz K (1973) A bound form of silicon in glycosami-
noglycans and polyuronides. Proc Natl Acad Sci USA
70:1608-1612
172. Berlyne GM, Caruso C (1983) Measurement of silicon
in biological fliuds in man using flameless furnace
atomic absorption spectrophotometry. Clin Chim Acta
129:239-244
173. Zhuoer H (1994) Silicon measurement in bone and other
tissues by electrothermal atomic absorption spectrometry. J
Anal Atomic Spect 9:11-15
174.lichte FE, Hopper S, Osborn TW (1980) Determination
of silicon and aluminum in biological matrices by induc-
tively coupled plasma emission spectrometry. Anal Chem
52:120-124
175. Sauer F, Laughland DH, Davidson WM (1959) Silica me-
tabolism in guinea pigs. Can J Biochem Physiol 37:183-191
176. Allain P, Cailleux A, Mauras Y, Renier JC (1983) Etude de
l'absorption digestive du silicium apres administration unique
chez I'homme sous forme de salicylate de methyl silane triol.
Therapie 38:171-174
177. Kelsay JL, Behall KM, Prather E (1979) Effect of fiber from
fruits and vegetables on metabolic responses of human
subjects. II. Calcium, magnesium, iron and silicon balances.
Am J Clin Nutr 32:1876-1880
178. Adler AJ, Etzion Z, Berlyne GM (1986) Update, distribution,
and excretion of 31 sil ico n in normal rats. Am J Physiol
251 :E670-E673
179. Berlyne GM, Adler A], Ferran N, et al (1986) Silicon me-
tabolism. I. Some aspects of renal silicon handling in nor-
mal men. Nephron 43:5-9
180. Carlisle EM (1981) Silicon in bone formation. In Simpson
TL, Volcani BE (eds), Silicon and siliceous structures in bio-
logical systems. Springer, New York, pp 69-94
181. Carlisle EM (1988) Silicon as a trace nutrient. SciTot Environ
73:95-106
182. Reeves CD, Volcani BE (1985) Role of silicon in diatom
metabolism. Messenger RNA and polypeptide accumulation
patterns in synchronized cultures of Cylindratheca fusiformis.
J Gen MicrobioI131:1735-1744
183. Seaborn CD, Nielsen FH (1993) Silicon: A nutritional be-
neficence for bones, brains and blood vessels? Nutr Today
28:13-18
184. Seaborn CD, Nielsen FH (1994) Effects of germanium and
silicon on bone mineralization. Bioi Trace Elem Res
42:151-164
185. Seaborn CD, Nielsen FH (1994) High dietary aluminum
affects the response of rats to silicon deprivation. Bioi Trace
Elem Res 41:295-304
186. Seaborn CD, Nielsen FH (1994) Dietary silicon affects acid
and alkaline phosphatase and 45 calci um uptake in bone of
rats. J Trace Elem Exp Med 7:11-18
187. Carlisle EM, Curran MJ (1987) Effect of dietary silicon and
aluminum on silicon and aluminum levels in the rat brain.
Alzheimer Dis Assoc Disorders 1:83-89
188. Benke GM, Osborn TW (1979) Urinary silicon excretion by
rats following oral administration of silicon compounds. Food
Cosmet Taxicol 17:123-127
189. Charnot Y, Peres G (1971) Contribution a I' etude de la
regulation endocrinienne du metabolisrne silicique. Ann
Endocrinal 32:397-402
190. Bowen HJM, Peggs A (1984) Determination of the silicon
content of food. J Sci Food Agric 35:1225-1229
191. Pennington JAT (1991) Silicon in foods and diets. FoodsAddit
Contam 8:97-118
192. Villota R, Hawkes JG (1986) Food applications and the toxi-
PRESENT KNOWLEDGE IN NUTRITION, 7th Edition
cological and nutritional implications of amorphous silicon
dioxide. CRC Crit Rev Food Sci Nutr 23:289-321
193. Najda I. Goss M, Gminski L et al (1994) The antioxidant
enzymes activity in the conditions of systemic hypersilicemia.
Bioi Trace Elem Res 42:63-70
194. Eisinger J, Clairet D (1993) Effects of silicon, fluoride,
etidronate and magnesium on bone mineral density: a ret-
rospective study. Magnes Res 6:247-249
195. Priestley J, Gamgee A (1876) On the physiological action
of vanadium. Philos Trans R Soc Lond [BioI] 166:495-556
196. Jackson DE (1912) The pharmacological action of vanadium.
J Pharmacol 3:477-514
197. Henze M (1911) Untersuchungen uber das Blut der Ascidien.
I. Mitt. DieVanadiumverbindung der Blutk6rperchen. Hoppe
Seylers Z Physiol Chem 72:494-501
198. Henze M (1912) Untersuchungen uber das Blut der Ascidien.
Hoppe Seylers Z Physiol Chem 79:215-228
199. Cantley LC Jr, Josephson L, Warner R, et al (1977) Vana-
date is a potent (Na,K)-ATPase inhibitor found in ATP de-
rived from muscle. J Bioi Chem 252:7421-7423
200. Orvig C, Thompson KH, Battell M, McNeill JH (1995) Va-
nadium compounds as insulin mimics. In Sigel H, Sigel A
(eds), Metal ions in biological systems, Vol 31, Vanadium
and its role in life. Marcel Dekker, New York, pp 575-594
201. Vilter H (1995) Vanadium-dependent-haloperoxidases. In
Sigel H, Sigel A (eds), Metal ions in biological systems, Vol
31, Vanadium and its role in life. Marcel Dekker, New York,
pp 325-362
202. Nielsen FH, Uthus EO (1990) The essentiality and metabo-
lism of vanadium. In Chasteen ND (ed), Vanadium in bio-
logical systems. Physiology and biochemistry. Kluwer Aca-
demic, Dordrecht, Netherlands, pp 51-62
203. Nechay BR, Nanninga LB, Nechay PSE, et al (1986) Role of
vanadium in biology. Fed Proc 45:123-132
204. Nielsen FH (1995)Vanadium in mammalian physiology and
nutrition. In Sigel H, Sigel A (eds), Metal ions in biological
systems, Vol 31, Vanadium and its role in life. Marcel Dekker,
New York, pp 543-573
205. Kustin K, Macara I (1982) The new biochemistry of vana-
dium. Comments Inorg Chem 2:1-22
206. Boyd DW, Kustin K (1984)Vanadium: a versatile biochemical
effector with an elusive biological function. Adv Inorg
Biochem 6:311-365
207. Nechay BR (1984) Mechanisms of action of vanadium. Annu
Rev Pharmacol Toxicol 24:501-524
208. Degani H, Gochin M, Karlish SJD, Schechter Y (1981)
Electron paramagnetic resonance studies and insulin-like
effects of vanadium in rat adipocytes. Biochemistry
20:5795-5799
209. liochev SI, Fridovich I (1990) Vanadate-stimulated oxida-
tion of NAD(P)H in the presence of biological membranes
and other sources of 02-' Arch Biochem Biophys 279:1-7
210. Fantus IG, Kadota S, Deragon G, et al (1989) Pervanadate
[peroxide(s) of vanadate] mimics insulin action in rat
adipocytes via activation of the insulin receptor tyrosine
kinase. Biochemistry 28:8864-8871
211. Wever R, Kustin K (1990) Vanadium: a biologically relevant
element. Adv Inorg Chem 35:81-115
212. Heydorn K (1990) Factors affecting the levels reported for
vanadium in human serum. Bioi Trace Elem Res 26/
27:541-551
213. Myron DR, Givand SH, Nielsen FH (1977) Vanadium con-
tent of selected foods as determined by f1ameless absorp-
tion spectroscopy. Agric Food Chem 25:297-300
214. Ishida 0, Kihira K, Tsukamoto Y, Marumo F (1989) Im-
proved determination of vanadium in biological fluids by
OTHER TRACE ELEMENTS/Nielsen
electrothermal atomic absorption spectrometry. Clin Chem
35:127-130
215. Byrne AR, Versieck J (1990) Vanadium determination at the
ultratrace level in biological reference materials and serum
by radiochemical neutron activation analysis. Bioi Trace Elem
Res 26/27:529-540
216. Byrne AR, KuCera J (1991) New data on levels of vanadium
in man and his diet. In Morneilovic B (ed), Trace elements
in man and animals 7. IMI, Zagreb, pp 25.18-25.20
217. Byrne AR, Kosta L (1978) Vanadium in foods and in human
body fluids and tissues. Sci Total Environ 10:17-30
218. Myron DR, Zimmerman TJ, Shuler TR, et al (1978) Intake
of nickel and vanadium by humans. A survey of selected
diets. Am J Clin Nutr 31 :527-531
219. Curran GL, Azarnoff DL, Bolinger RE (1959) Effect of cho-
lesterol synthesis inhibition in nomocholesteremic young
men. J Clin Invest 38:1251-1261
220. Hansard SL II, Ammerman CB, Henry PR (1982) Vanadium
metabolism in sheep. II. Effect of dietary vanadium on per-
formance, vanadium excretion and bone deposition in sheep.
J Anim Sci 55:350-356
221. Parker RDR, Sharma RP (1978) Accumulation and deple-
tion of vanadium in selected tissues of rats treated with
vanadyl sulfate and sodium orthovanadate. J Environ Pathol
Toxicol 2:235-245
222. Roschin AV, Ordzhonikidze EK, Shalganova IV (1980) Va-
nadium-toxicity, metabolism, carrier state. J Hyg Epidemiol
Microbiol Immunol 24:377-383
223. Bogden JD, Higashino H, Lavenhar MA, et al (1982) Bal-
ance and tissue distribution of vanadium after short-term
ingestion of vanadate. J Nutr 112:2279-2285
224. Wiegmann TB, Day HD, Patak RV (1982) Intestinal absorp-
tion and secretion of radioactive vanadium (4BV03 - ) in rats
and effect of AI(OH)" JToxicol Environ Health 10:233-245
225. Patterson BW, Hansard SL II, Ammerman CB, et al (1986)
Kinetic model of whole-body vanadium metabolism: stud-
ies in sheep. Am J Physiol 251 :R325-R332
226. Chasteen ND, Lord EM, Thompson HJ (1986) Vanadium
metabolism. Vanadyl (IV) electron paramagnetic resonance
spectroscopy of selected tissues in the rat. In Xavier AV (ed),
Frontiers in bioinorganic chemistry. VCH Verlagsgesellschaft,
Weinhein, pp 133-141
227. Sabbioni E, Marafante E (1978) Metabolic patterns ofvana-
dium in the rat. Bioinorg Chem 9:389-407
228. Hopkins LL jr, Tilton BE (1966) Metabolism of trace amounts
of vanadium 48 in rat organs and liver subcellular particles.
Am J Physiol 211 :169-172
229. Edel J, Sabbioni E(1989) Vanadium transport across placenta
and milk of rats to the fetus and newborn. Bioi Trace Elem
Res 22:265-275
230. Sabbioni E, Marafante E (1981) Relations between iron and
vanadium metabolism: in vivo incorporation of vanadium
into iron proteins of the rat. J Toxicol Environ Health
8:419-429
231. Harris WR, Friedman SB, Silberman D (1984) Behavior of
vanadate and vanadyl ion in canine blood. J Inorg Biochem
20:157-169
232. ESabbioni, EMarafante (1981) Progress in research on newer
trace elements: the metabolism of vanadium as investigated
by nuclear and radiochemical techniques. In McC Howell
J, Gawthorne JM, White CL (eds), Trace element metabo-
lism in man and animals (TEMA-4). Australian Academy of
Science, Canberra, pp 629-631
233. Hansard SL II, Ammerman CB, Fick KR, Miller SM (1978)
Performance and vanadium content of tissues in sheep as
influenced by dietary vanadium. J Anim Sci 46:1091-1095
375
234. Willsky GR (1990) Vanadium in the biosphere. In Chasteen
ND (ed), Vanadium in biological systems. Physiology and
biochemistry. Kluwer, Dordrecht, Netherlands, pp 1-24
235. Stern A, Yin X, Tsang 5-5, et al (1993) Vanadium as a modu-
lator of cellular regulatory cascades and oncogene expres-
sion. Biochem Cell Bioi 71:103-112
236. Wever R, Krenn BE (1990) Vanadium haloperoxidases. In
Chasteen ND (ed), Vanadium in biological systems. Physi-
ology and biochemistry. Kluwer, Dordrecht, Netherlands, pp
81-97
237. van Schijndel JWPM, Vollenbroek EGM, Wever R (1993)
The chloroperoxidase from the fungus Curvu/aria inae-
qua/is; a novel vanadium enzyme. Biochim Biophys Acta
1161:249-256
238. Soedjak HS, Butler A (1991) Mechanism of dioxygen for-
mation catalyzed by vanadium bromoperoxidase from
Macrocystis pyrifera and Fucus distich us: steady state kinetic
analysis and comparison to the mechanism ofV-BrPO from
Ascophy/lum nodosum. Biochim Biophys Acta 1079:1-7
239. Eady RR (1995) Vanadium nitrogenases of Azotobacter. In
Sigel H, Sigel A (eds), Metal ions in biological systems, Vol
31, Vanadium and its role in life. Marcel Dekker, New York,
pp 363-405
240. Bayer E (1995) Amavadin, the vanadium compound of
Amanitae. In Sigel H, Sigel A (eds), Metal ions in biological
systems, Vol 31, Vanadium and its role in life. Marcel Dekker,
New York, pp 407-421
241. Frausto da Silva JjR(1989) Vanadium in biology-the case
of the Amanita toadstools. Chern Spec Bioavail 1:139-150
242. Anke M, Groppel B, Gruhn K, et al (1989) The essential-
ity of vanadium for animals. In Anke M, Baumann W,
Braunlich H, et al (eds), 6th International Trace Element
Symposium, 1989, Vol 1. Friedrich-Schiller-Universitat, lena,
pp 17-27
243. Uthus EO, Nielsen FH (1990) Effect of vanadium, iodine and
their interaction on growth, blood variables, liver trace
elments and thyroid status indices in rats. Magnesium Trace
Elem 9:219-226
244. Poellot RA, Seaborn CD, Uthus EO (1992) The effect of
vanadium deprivation in thyroxine replete-thyroidectomized
rats. Proc ND Acad Sci 46:75
245. Nielsen FH (1987) Vanadium. In Mertz W (ed), Trace ele-
ments in human and animal nutrition, Vol 1. Academic Press,
San Diego, pp 275-300
246. Schroeder HA, Balassa ll. Tipton IH (1963) Abnormal trace
metals in man-vanadium. J Chronic Dis 16:1047-1071
247. Somerville J, Davies B (1962) Effect of vanadium on serum
cholesterol. Am Heart J 64:54-56
248. Dimond EG, Caravaca J, Benchimol A (1963) Vanadium.
Excretion, toxicity, lipid effect in man. Am J Clin Nutr
12:49-53
249. Proescher F, Seil HA, Stillians AW (1917) A contribution to
the action of vanadium with particular reference to syphillis.
Am J Syph 1:347-405
250. Angelow L, Anke M, Groppel B, et al (1993) Aluminum: an
essential element for goats. In Anke M, Meissner D, Mills
CF (eds),Traceelements in man and animals, TEMA 8. Verlag
Media Touristik, Gersdorf, pp 699-704
251. Carlisle EM, Curran MJ (1993) Aluminum: an essential ele-
ment for the chick. In Anke M, Meissner D, Mills CF (eds),
Trace elements in man and animals, TEMA 8. Verlag Media
Touristik, Gersdorf, pp 695-698
252. Sternweis PC, Gilman AG (1982) Aluminum: a requirement
for activation of the regulatory component of adenylate
cyclase by fluoride. Proc Natl Acad Sci USA 79:4888-4891
253. JohnsonNE, Zierold C, Dunn MA (1991jAIUmmUm
376
calmodulin activity. In Momeilovic B (ed), Trace elements
in man and animals 7. IMI, Zagreb, pp 17:15-17:16
254. Smith JB (1984) Aluminum ions stimulate DNA synthesis in
quiescent cultures of Swiss 3T3 and 3T6 cells. J Cell Physiol
118:298-304
255. Quarles LD, Hartle JE II, Middleton JP, et al (1994) Alumi-
num-induced DNA synthesis in osteoblasts: mediation by a
G-protein coupled cation sensingmechanism. JCell Biochem
56:106-117
256. Greger JL (1993) Aluminum metabolism. Annu Rev Nutr
13:43-63
257. Anke M, Groppel B, Arnhold W, Langer M (1988) Essenti-
ality of the trace element bromine. In Braetter P, Schramel
P (eds), Trace element analytical chemistry in medicine and
biology. Walter de Gruyter, Berlin, pp 618-626
258. Anke M, Groppel B, Angelow L, et al (1993) Bromine: an
essential element for goats. In Anke M, Meissner 0, Mills
CF (eds),Trace elements in man and animals, TEMA 8. Verlag
Media Touristik, Gersdorf, pp 737-738
259. Huff JW, Bosshardt OK, Miller OP, Barnes RH (1956) A
nutritional requirement for bromine. Proc Soc Exp Bioi Med
92:216-219
260. Bosshardt OK, Huff JW, Barnes RH (1956) Effect of bromine
on chick growth. Proc Soc Exp Bioi Med 92:219-221
261. Leach RM [r, Nesheim MC (1963) Studies on chloride defi-
ciency in chicks. J Nutr 81:193-199
262.0e PL, Vis RD, Meijer JH, et al (1981) Bromine deficiency
and insomnia in patients on dialysis. In McC Howell l.
Gawthorne JM, White CL (eds), Trace element metabolism
in man and animals, TEMA-4. Australian Academy of Sci-
ence, Canberra, pp 526-529
263. Nielsen FH (1986) Other elements: Sb, Ba, B, Br, Cs, Ge,
Rb, Ag, Sr, Sn,n. Zr, Be, Bi, Ga, Au, In, Nb, Sc, Te, TI, W.
In Mertz W (ed), Trace elements in human and animal nu-
trition, Vol 2. Academic Press, Orlando, FL, pp 415-463
264. Schwarz K, Spallholz JE (1979) The potential essentiality
of cadmium. In Bolek F, Anke M, Schneider H-J (eds),
Kadmium-Symposium. Friedrich-Schiller Universitat, Iena,
pp 188-194
265. Reeves PG, Johnson PE, Rossow KL (1994) Absorption and
organ accumulation of cadmium in male rats fed diets con-
taining sunflower kernels [abstract]. FASEB J 8:A 196
266. Anke M, Hennig A, Groppel B, et al (1978) The biochemi-
cal role of cadmium. In Kirchgessner M (ed), Trace element
metabolism in man and animals-3. Tech Univ Munchen,
Freising-Weihenstephen, pp 540-548
267. Barham SS, TararaJE, Enger MD (1985) Cadmium as a trans-
forming growth factor [abstract]. Fed Proc 44:520
268. Kostial K (1986) Cadmium. In Mertz W (ed), Trace elements
in human and animal nutrition, Vol 2. Academic Press,
Orlando, pp 319-345
269. Schwarz K, Milne DB (1972) Fluorine requirement for growth
in the rat. Bioinorg Chem 1:331-338
270. Anke M, Groppel B, Krause U (1991) Fluorine deficiency
in goats. In Momeilovic B (ed), Trace elements in man and
animals 7. IMI, Zagreb, 1lP 26:28-26:29
27J. Avtsyn AP, Anke M, Zhavoronkov AA, et al (1993) Patho-
logical anatomy of the experimentally-induced fluorine
deficiency in she-goats. In Anke M, Meissner 0, Mills CF
(eds), Trace elements in man and animals, TEMA 8. Verlag
Media Touristik, Gersdorf, pp 745-746
272. Messer HH, Armstrong WD, Singer L (1974) Essentiality and
function of fluoride. In Hoekstra WG, Suttie JW, Ganther
HE, Mertz W (eds), Trace element metabolism in animals-
2. University Park Press, Baltimore, pp 425-437
273. Wegner ME, Singer L, Ophaug RH, Magi! SG (1976). The
PRESENT KNOWLEDGE IN NUTRITION, 7th Edition
interrelation of fluoride and iron in anemia. Proc Soc Exp
Bioi Med 153:414-418
274.Jenkins GN (1990) The metabolism and effects of fluoride.
In Priest NO, Van De Vyver FL (eds), Trace metals and fluo-
ride in bones and teeth. CRC Press, Boca Raton, FL, pp
141-173
275. Grooten HNA, Ritskes-Hoitinga), Mathot JNJ), et al (1991)
Dietary fluoride prevents phosphorus-induced nephro-
calcinosis in female rats. Bioi Trace Elem Res 29:147-155
276. Fransbergen AJ, Lemmens AG, Beynen AC (1991) Dietary
fluoride, unlike bromide or iodide, counteracts phospho-
rus-induced nephrocalcinosis in female rats. Bioi Trace Elem
Res 31 :71-78
277. Sato I, Yuan BD, Nishimura T, Tanaka N (1985) Inhibition
of tumor growth and metastasis in association with modifi-
cation of immune response by novel organic germanium
compounds. J Bioi Response Mod 4:159-168
278. Suzuki F, Brutkiewicz RR, Pollard RB (1986) Cooperation
of Iymphokine(s) and macrophages in expression of antitu-
mor activity of carboxyethylgermanium sesquioxide (Ge-
132). Anticancer Res 6:177-182
279. Schwarz K (1975) Potential essentiality of lead. Arh Hig Rada
Toksikol 26(suppl):13-28
280. Kirchgessner M, Reichlmayr-Lais AM (1981) Lead deficiency
and its effects on growth and metabolism. In McC Howell
J, Gawthorne JM, White CL (eds), Trace element metabo-
lism in man and animals, TEMA 4. Australian Academy of
Science, Canberra, pp 390-393
281. Reichlmayr-Lais AM, Kirchgessner M (1985) Newer research
on lead essentiality. In Mills CF, Bremner I, ChestersJK (eds),
Traceelements in man and animals, TEMA 5. Commonwealth
Agricultural Bureaux, Farnham Royal, pp 283-286
282. Reichlmayr-Lais AM, Kirchgessner M (1991) Lead-an es-
sential trace element. In Momeilovic B (ed), Trace elements
in man and animals, 7. IMI, Zagreb, pp 35:1-35:2
283. Kirchgessner M, Plass DL, Reichlmayr-Lais AM (1991) Lead
deficiency in swine. In Momeilovic B (ed), Trace elements
in man and animals, 7. IMI, Zagreb, pp 11:20-11:21
284. Uthus EO, Nielsen FH (1988) Effects in rats of iron on lead
deprivation. Bioi Trace Elem Res 16: 155-163
285. Muller M, Anke M, Thiel C, Hartmann E (1993) Exposure
of adults to lead from food estimated by analysis and cal-
culation-comparison of methods. In Anke M, Meissner 0,
Mills CF (eds), Trace elements in man and animals, TEMA
8. Verlag Media Touristik, Gersdorf, pp 241-242
286. Anke M, Arnhold W, Groppel B, Krause U (1990) The bio-
logical importance of lithium. In Schrauzer GN, Klippel K-
F (eds), Lithium in biology and medicine. VCH Publishers,
Weinheim, pp 148-167
287. Patt EL, Pickett EE, O'Dell BL (1978) Effect of dietary lithium
levels on tissue lithium concentrations, growth rate, and
reproduction in the rat. Bioinorg Chem 9:299-310
288. Pickett EE, O'Dell BL (1992) Evidence for dietary essential-
ity of lithium in the rat. Bioi Trace Elem Res 34:299-319
289. Rybak SM, Stockdale FE (1981) Growth effects of lithium
chloride in BALB/c 3T3 fibroblasts and Madin-Darby canine
kidney epithelial cells. Exp Cell Res 136:263-270
290. Rossetti L, Giaccari A, Klein-Robbenhaar E, Vogel LR
(1990) Insulinomimetic properties of trace elements and
characterization of their in vivo mode of action. Diabe-
tes 39:1243-1250
291. Schrauzer GN, Shrestha KP (1990) Lithium in drinking water
and the incidence of crimes, suicides, and arrests related
to drug addictions. Bioi Trace Elem Res 25:105-113
292. Schrauzer GN, Shrestha Kp, Flores-Arce MF (1992) Lithium
in scalp hair of adults, students, and violent criminals. Ef-
OTHER TRACE ELEMENTS/Nielsen
fects of supplementation and evidence for interactions of
lithium with vitamin B-12 and with other trace elements.
Bioi Trace Elem Res 34:161-176
293. Anke M, Angelow L, SchmidtA, Gurtler H (1993) Rubidium:
an essential element for animal and man? In Anke M,
Meissner D, Mills CF (eds), Trace elements in man and
animals, TEMA 8. Verlag Media Touristik, Gersdorf, pp
719-723
294. Eisa 0, Yudkin J (1989) Mineral elements in unrefined sugar,
and rat reproduction. Int J Vitam Nutr Res 59:77-79
295. Angelow L, Anke M (1994) Rubidium in der Nahrungskette.
In Anke M, Meissner D, Bergmann H, et al (eds), Defizite
und Oberschusse an Mengen-und Spurenelementen in der
Ernahrung. 14. Arbeitstagung Mengen-und Spurenelemente
1994. Verlag Harald Schubert, Leipzig, pp 285-300
296. Schwarz K, Milne DB, Vinyard E (1970) Growth effects of
tin compounds in rats maintained in a trace element-con-
377
trolled environment. Biochem Biophys Res Commun
40:22-29
297. Yokoi K, Kimura M, Itokawa Y (1990) Effect of dietary tin
deficiency on growth and mineral status in rats. Bioi Trace
Elem Res 24:223-231
298. Kappas A, Drummond GS, Simionatto CS, Anderson KE
(1984) Control of heme oxygenase and plasma levels of
bilirubin by a synthetic heme analogue, Tin-protoporphy-
rin. Hepatology 4:336-341
299. Kappas A, Drummond GS (1984) Control of heme and cy-
tochrome P-450 metabolism by inorganic metals, organo-
metals and synthetic metalloporphyrins. Environ Health
Perspect 57:301-306
300. Cardarelli N (1990) Tin and the thymus gland: a review.
Thymus 15:223-231
301. Greger JL (1988) Tin and aluminum. In Smith KT (ed), Trace
minerals in foods. Marcel Dekker, New York, pp 291-323